Cabinet of Ministers Regulations No. 349 in Riga 2010 April 13 (Mon. No. 6) Amendment 19 Cabinet on 19 July 2005, the provisions of the "rules on no 528 national agency" infektoloģij Center "public service price list" Issued in accordance with the law on budget and financial management of the ninth paragraph of article 5 to make a Cabinet of 19 July 2005, regulations No 528 "rules for State agencies Kuma" infektoloģij Center "public service price list" (Latvian journal, 2005, 115 No; 2006, 2007 101 no; 88. no; 2008, 114 no; in 2009, 72, 169. No.) amendments and express attachment as follows: "Cabinet of Ministers on 19 July 2005, regulations No 528 national agency" infektoloģij Center "public service price list no PO box
The type of service the unit price without VAT (Ls) SALES TAX ($) price with VAT (Ls) (I). the public services on which the associated costs shall not be covered from the State budget Vakcinācija1 1.1 1. vaccination against tick encephalitis 1.1.1. vaccination against tick encephalitis (adults) 1 vaccination 21.50 0.00 21.50 1.1.2. vaccination against tick encephalitis (children) 1 vaccination 21.00 0.00 21.00 1.2. vaccination against rabies vaccination 14.00 0.00 14.00 1.3 1. vaccination against yellow fever vaccination 18.00 0.00 18.00 1.4 1. vaccination against viral hepatitis in 1.4.1. vaccination against viral hepatitis A (adults) 1 vaccination 22.00 0.00 22.00 1.4.2. vaccination against viral hepatitis A (child) 1 vaccination, vaccination against viral hepatitis 19.00 0.00 19.00 1.4.3. B (adults) 1 vaccination 12.00 0.00 12.00 1.4.4. vaccination against viral hepatitis B (children) 1 vaccination 1.4.5. vaccination against viral hepatitis 9.00 0.00 9.00 A and viral hepatitis B (combined vaccine in a single dose) 1 vaccination 31.00 0.00 31.00 1.5. vaccination against chickenpox vaccination 30.00 0.00 30.00 1.6 1. vaccination against typhoid fever vaccination 12.00 0.00 12.00 1.7 1. vaccination against polio diphtheria, the numbness of cramps 1 vaccination 11.00 0.00 11.00 1.8. vaccination against meningococcal infection 1 vaccination 14.00 0.00 14.00 1.9. vaccination against pneumococcal infection 1 vaccination 15.00 0.00 15.00 1.10. vaccination against influenza vaccination against influenza 1.10.1. (adults) 1 vaccination, vaccination against influenza 8.00 0.00 8.00 1.10.2. (children) 1 vaccination 7.00 0.00 7.00 1.11. vaccination against cholera vaccination 23.00 0.00 23.00 1 1.12. vaccination against epidemic of mumps of , measles, rubella vaccination 1 12.00 0.00 12.00 1.13. international certificate of vaccination or booster vaccination against yellow fever certificate 0.60 0.13 0.73 1 1.14. off-site vaccination 1.14.1. working collective vaccination (up to 50 people) 1 sail 12.00 0.00 12.00 1.14.2. vaccination work collective (from 51 to 100 people) 1 sail 22.00 0.00 22.00 1.14.3. vaccination work collective (from 101 to 200 people) 1 sail 32.00 0.00 32.00 1.14.4. vaccination work collective (from 201 to 300 people) 1 sail 2 42.00 0.00 42.00. Dental pakalpojumi2 3 2.1. first visit (advice) 1 consultation 6.13 0.00 6.13 2.2. preparation of the workplace before each visit, including once to use the materials, tools and the top three staff training 1 procedure 2.3.1.34 0.00 1.34 dental hygiene index determination before professional dental hygiene, or periodontīt disease treatment more frequently than twice a year, 1 procedure 1.12 0.00 1.12 2.4. gum bleeding index determination before professional dental hygiene, or periodontīt disease treatment more frequently than twice a year, 1 procedure 0.71 0.00
0.71 2.5. periodontīt index (CPITN) using the graduated pogveid probe, before professional dental hygiene, or periodontīt disease treatment more frequently than twice a year (may show with 2.3 or 2.4. apakšpun JTIS in manipulation) 1 procedure 1.86 0.00 1.86 2.6. first full periodontīt investigations carried out periodontolog or specialist in one patient one time year 1 procedure 8.10 0.00 8.10 2.7 periodontīt investigation. by periodontolog in or specialist, compared to periodontīt in the first inquiry procedure 1 5.41 0.00 5.41 2.8. determination of tooth vitality one tooth 1 procedure in dental x-ray 2.9 0.55 0.00 0.55 a written evaluation evaluation 1 0.30 0.00 0.30 2.10. hygiene instruction and motivation, oral care and prevention demonstrations 1 instruction 2.02 0.00 2.02 2.11. tooth surface treatment by means of pretkaries-gel or foam application procedure 1 0.78 0.00 0.78 2.12. tooth removal throughout the soft mouth fever 1 procedure
2.52 0.00 2.52 2.13 tooth polishing throughout the mouth 1 procedure 2.45 0.00 2.45 2.14 dental hard across the mouth of the pigment removal procedure 1 6.29 0.00 6.29 2.15. tooth of kavitāt building and temporary closures, carried out in cases where planned to make inlej or other prosthetic elements, as well as if there are profound caries 1 procedure one parapulpār 2.16.3.80 0.00 3.80 pins or screw fitting 1 channel procedure 1.29 0.00 1.29 2.17. milk teeth amalgam 1 surface,, 1 procedure 4.34 0.00 4.34 2.18. milk teeth, amalgam, 2 surface 1 procedure 5.55 0.00 5.55 2.19. milk teeth, amalgam, 3 surface 1 procedure 6.49 0.00 6.49 2.20. milk teeth, amalgam, 4 surface 1 procedure 7.44 0.00 7.44 2.21. milk teeth, glass jonomēr, 2 surface 1 procedure 6.08 0.00 6.08 2.22. milk teeth, kompomēr, 1 surface 1 procedure 4.79 0.00 4.79 2.23. milk teeth , kompomēr, 2 surface 1 procedure 6.37 0.00 6.37 2.24. milk teeth, molar, standard metal Crown 1 procedure 7.85 0.00 7.85 2.25. Quicksilver, incisīv and premolār, 1 surface 1 procedure 5.22 0.00 5.22 2.26 amalgam, premolār, 2 surface 1 procedure 6.46 0.00 6.46 2.27 amalgam, premolār, 3 surface 1 procedure premolār 2.28. Quicksilver, 7.22 0.00 7.22, 4 surface 1 procedure 9.06 0.00 9.06 2.29 amalgam , premolār, clinical Crown restoration procedure 1 18.17 0.00 18.17 2.30. amalgam, molar, 1 surface 1 procedure 5.38 0.00 5.38 2.31. Quicksilver, molar, 3 surfaces 1 procedure 6.69 0.00 6.69 2.32 amalgam, molar, 3 surfaces 1 procedure 7.43 0.00 7.43 2.33 amalgam, molar, 4 surface and more 1 procedure 10.43 0.00 10.43 2.34. Quicksilver, molar, clinical Crown restoration procedure 1 glass jonomēr for 20.12 0.00 20.12 2.35 , incisīv, 1 surface 1 procedure 5.93 0.00 5.93 2.36. jonomēr glass, incisīv, 2 surface 1 procedure 7.08 0.00 7.08 2.37 jonomēr glass, premolār, 1 surface procedure 5.93 0.00 5.93 2.38 1 glass, 1 jonomēr, 1 molar surface 6.76 0.00 6.76 2.39. kompomēr procedure, incisīv, 1 surface 1 procedure 6.36 0.00 6.36 2.40. kompomēr, 1 incisīv, 2 surface kompomēr of procedure 7.51 0.00 7.51 2.41. , premolār, 1 surface 1 procedure 6.35 0.00 6.35 2.42 kompomēr, molar, 1 surface 1 procedure 6.51 0.00 6.51 2.43. composite, incisīv, 1 surface using only the light of composite materials hardening procedure 1 7.64 0.00 7.64 2.44 composite, incisīv, 2 surface using only the light-hardening materials 1 composite procedure 8.77 0.00 8.77 2.45. composite, incisīv, 3 surface using only the light-hardening materials 1 composite procedure 10.86 0.00 10.86 composite 2.46. , incisīv, 4 surface using only the light of composite materials hardening procedure 12.29 0.00 12.29 2.47 1. composite, incisīv, 5 surface using only the light-hardening materials 1 composite procedure 2.48 14.70 0.00 14.70. milk teeth, vital for the molar 1 procedure pulpotomij 5.62 0.00 5.62 2.49. milk teeth, mortāl pulpotomij the molar in the first session, – pulp devitalizācij, cost included in the temporary closure of the kavitāt procedure 1 3.46 0.00 3.46 2.50. milk teeth mortāl in pulpotomij of the molar, – second session 1 procedure 3.22 0.00 3.22 2.51. milk teeth, pulpektomij the incisīv with a root canal treatment, cost included in the temporary closure of the kavitāt procedure 1 6.72 0.00 6.72 2.52. milk teeth, pulpektomij-incisīv, root canal filling, included in the cost of processing and kavitāt temporary closure of 1 procedure 3.38 0.00 3.38 2.53. milk teeth, pulpektomij, the molar root canal treatment procedure 7.89 0.00 7.89 2.54 1. milk teeth pulpektomij, the molar, root canal filling 1 procedure 5.30 0.00 5.30 v.2.55. vital pulpotomij (apeksģenēz) the permanent teeth with not looking roots, after the part of the Crown pulp amputation using calcium preparations 1 procedure 6.06 0.00 6.06 2.56. vital pulpotomij premolār and not looking for immediate help as molar at permanent pulpīt, if there is no time to do 1 procedure pulpektomij. acute pulpektomij-2.57 5.79 0.00 5.79 viensakn's teeth as emergency assistance to the permanent pulpīt or pulp injury 1 procedure pulpektomij-2.58 6.82 0.00 6.82. acute divsakņ teeth as the emergency assistance to the permanent pulpīt or pulp injury 1 procedure for pulpektomij acute 8.85 0.00 8.85 2.59. trīssakņ teeth as emergency assistance to the permanent pulpīt or pulp injury 1 procedure 10.93 0.00 10.93 2.60.

acute pulpektomij teeth with anatomical additional channels as emergency assistance to the permanent pulpīt or pulp injury 1 procedure 2.61. acute 3.07 0.00 3.07, dead teeth and open drainage of viensakn teeth as emergency assistance, if it is not acute life tooth 1 procedure 6.82 0.00 6.82 2.62. acute, dead teeth and open drainage divsakņ teeth as emergency assistance, if it is not acute life tooth 1 procedure acute 9.01 0.00 9.01 2.63. , dead teeth and open drainage trīssakņ teeth as emergency assistance, if it is not acute life tooth 1 procedure 10.29 0.00 10.29 2.64. root canal treatment of tooth 1 procedure viensakn 4.66 0.00 4.66 2.65. root canal filling of teeth 1 procedure viensakn 3.75 0.00 3.75 2.66. root canal treatment of tooth 1 procedure diphthongs 5.95 0.00 5.95 2.67. root canal divsakņ dental filling procedure 6.05 0.00 6.05 2.68 1. root canal treatment of tooth trīssakņ 1 procedure 9.85 0.00 9.85 2.69. root canal filling of trīssakņ Dental procedure 8.06 0.00 8.06 2.70 1. root canal teeth of the pārārstēšan of viensakn 1 procedure root canal 8.13 0.00 8.13 2.71. pārārstēšan a divsakņ tooth 1 procedure root canal 9.41 0.00 9.41 2.72. pārārstēšan a trīssakņ tooth 1 procedure to treat endodontisk 2.73 11.60 0.00 11.60. tooth Crown restoration before the imposition of the cofferdams 1 procedure endodontisk of 8.33 0.00 8.33 2.74. treat tooth opening through the Crown 1 procedure endodontisk treatment of 3.10 0.00 3.10 2.75. tooth whitening – first impressions 1 procedure for 5.12 0.00 5.12 2.76. endodontisk treatment tooth whitening – each subsequent session 1 4.24 0.00 4.24 2.77. moving procedure the milk tooth extraction procedure 1.78. viensakn teeth of 2.40 0.00 2.40 extraction, including wounds finish 1 procedure 4.15 0.00 4.15 2.79. daudzsakņ tooth extraction, including wounds finish 1 procedure 7.40 0.00 7.40 2.80. bone leveling, izkasīšan, seam, tamponēšan-special zobārstniecisk assistance provided in separate session on one side of the jaw or District 1 procedure erupted 8.05 0.00 8.05 2.81. viensakn tooth extraction with the osteotomij of the , including wounds finish 1 procedure daudzsakņ tooth 9.03 0.00 9.03 2.82. extraction with osteotomij, including wounds finish 1 procedure 11.03 0.00 11.03 2.83. alveolar sekvestrektomij spur 1 procedure 16.87 0.00 16.87 2.84 stop bleeding after tooth extraction, used separate session as the closure of the extraction wound with stitches, 1 procedure 7.00 0.00 7.00 2.85. deep localized abscess in the intraorāl procedure 1 open the alveoli kiretāž 2.86 14.06 0.00 14.06. procedure 1. mucosal disease 4.41 0.00 4.41 2.87 local drug treatment or prosthetic fingerprint site treatments in one session 1 procedure 4.10 0.00 4.10 2.88 suture removal procedure 0.81 0.00 0.81 2.89 1. acute uncomplicated infection of oral treatment for one visit 1 procedures 4.21 0.00 4.21 2.90. acute uncomplicated infection of oral treatment for two visits 1 procedure 7.56 0.00 7.56 2.91. Tartar removal per unit of time (15 min) 1 4.98 0.00 4.98 2.92. procedure to remove tartar two time units (30 min), 1 procedure for removing Tartar 8.73 0.00 8.73 2.93. the four time units (60 min) 1 procedure for removing Tartar 15.26 0.00 15.26 2.94. six units of time (90 min) 1 procedure 21.59 0.00 21.59 2.95. gingival Pocket rinsing with antimicrobial solution in one unit of time (15 min) procedure 1. gingival Pocket 1.96 0.00 1.96 2.96 rinse with antibacterial solutions in two units of time (30 min), 1 procedure 3.36 0.00 3.36 2.97. fibrous local insert with medication withdrawal from gum pockets one dental procedure 6.54 0.00 6.54 2.98 1. gingival Pocket kiretāž one tooth 1 procedure 6.67 0.00 6.67 2.99.
gum pocket of each subsequent tooth kiretāž 1 procedure periodontāl of 3.58 0.00 3.58 2,100. perikoronīt treatment of abscesses or one visit procedure 1 5.60 0.00 5.60 2101. periodontāl treatment of perikoronīt abscess or two visits 1 procedure periodontāl-9.82 0.00 9.82 2.102. perikoronīt treatment of abscesses or three visits 1 procedure 13.88 0.00 13.88 2.103 cofferdams, taxation procedure 1 remove the surface anaesthesia 2.104 0.98 0.00 0.98. used to manipulate, which is not included in the cost of other types of anesthesia procedure 1 0.42 0.00 0.42 2.105 infiltration anesthesia procedure 1. intraorāl its 1.37 0.00 1.37 2,133 anesthesia procedure 1 1.95 0.00 1.95 2.107. tooth Canal filling with dental-specific material (screw) 1 procedure 5.86 0.00 5.86 3. Specific tuberculosis tuberculosis ārstēšana1 3.1 specific therapy of tuberculosis patient, sensitive, if the medication intravenously is entered in one day 1 treatment procedure 3.2 20.00 0.00 20.00 tuberculosis specific therapy of tuberculosis patients who (a treatment for without kapreomicīn) one day 1 treatment procedure 3.3 12.00 0.00 12.00 tuberculosis specific therapy of tuberculosis patients who (a treatment with kapreomicīn) in one day of treatment 1 procedure 4. Service 23.00 0.00 23.00 Services1 4.1 with treatment-related pakalpojumi3 4.1.1. patient into a single Chamber of patients 4.1.2 8.00 0.00 8.00 1 days into boxing days of 12.00 0.00 12.00 1 4.1.3. hospital profile patient days (without the diagnostic studies) 1 days 40.00 0.00 40.00 4.1.4 of the days of the surgery patients TPSK profile (without the diagnostic studies) 1 days a
4.1.5. the days of 50.00 0.00 50.00 TPSK intensive care patient profile (without the diagnostic studies) 1 days of 120.00 0.00 120.00 4.2 medical records copying 4.2.1. A5 copy with copy machine for A5 page A4 0.04 0.01 0.05 4.2.2. copies with copy machine for A4 sheet 0.05 0.01 0.06 4.2.3. preparation and issuance of the statement by the patient's written request within one week 1 document 4.28 0.90 5.18 4.2.4. preparation and issuance of the statement the next day after receipt of the request 1 document 6.93 1.46 8.39
4.2.5. the translation of the statement in a foreign language (English or Russian) 1 document 5.78 1.21 6.99 4.2.6. inability to duplicate issue 1 page document 1.00 0.21 1.21 4.2.7. cognitive preparation (for I have been ill I have been ill with not tuberculosis, STDs), describing the results of the study 1 document 3.00 0.63 3.63 5. Methodical consultative darbs1 5.1 laboratory specialist training (with the exception of the epidemiological surveillance laboratory professionals) 1 academic hour of laboratory methods 6.38 1.34 7.72 5.2 training 5.3 1 participant 6.38 1.34 7.72 thematic workshop on laboratory diagnosis (of each member) 1 member 9.60
2.02 11.62 5.4. lecture on diagnosis (of each member) 1 member training in vakcinoloģij 3.17 0.67 3.84 5.5 infektoloģij Centre of Latvia's vaccination (from each participant) (1) a participant in the training bronholoģij 5.6 12.76 2.68 15.44 1 week training in 80.00 16.80 96.80 5.7 thoracic surgery 1 week training in Pulmonology 80.00 16.80 96.80 5.8 1 month 5.9 150.00 31.50 181.50 methodically advisory work in the prevention of infectious diseases issues 1 study of infektoloģij training in 12.76 2.68 15.44 5.10 and/or 45.45 9.55 55.00 hepatoloģij in 1 week
6. Oftalmoloģija1 okulist 6.1 inspection and spectacle out 1 study 3.50 0.00 3.50 6.2. eye pressure measurement 1 procedure retinoskopij-0.50 0.00 0.50 6.3. adults and children at 8 years of age 1 1.04 0.00 1.04 6.4. retinoskopij procedure for children up to 8 years of age 1 procedure 1.54 0.00 1.54 6.5. oftalmometrij (keratometrij) 1 procedure 0.40 0.00 0.40 6.6. determination of Visual acuity in children up to 8 years of age 1 procedure 0.80 0.00 0.80 6.7. determination of Visual acuity with correction for children up to 8 years age 1 0.80 0.00 0.80 6.8. procedure for the determination of Visual acuity for adults and children at 8 years of age 1 procedure 0.66 0.00 0.66 6.9. determination of Visual acuity with correction for adults and children at 8 years of age 1 procedure 0.66 0.00 0.66 6.10. tear the withdrawal quantity and/or break time (break-up time) detection 1 procedure autorefraktometrij-0.93 0.00 0.93 6.11 1 procedure contact adjustment 2.19 0.00 2.19 6.12. the application 1 procedure 1.37 0.00 1.37 6.13. contact lens wear training 1 procedure 1.72 0.00
1.72 6.14. determination of the nature of vision with a 4 point color test procedure 1 0.46 0.00 0.46 6.15. stereoredz check (Lang, TNC and "flies" tests) 1 procedure 0.72 0.00 0.72 6.16. the top eyelid cut one eye procedure 0.35 0.00 0.35 1 6.17. eyes massage one eye 1 procedure 0.70 0.00 0.70 6.18. color vision test with the help of the color table 1 procedure biomikroskopij-6.19.0.35 0.00 0.35 eye both eyes 1 procedure gonioskopij-1.31 0.00 1.31 6.20. both eyes evaluation results 1 procedure 1.62 0.00 1.62 6.21.

biomikrooftalmoskopij of both eyes, the result of the evaluation procedure 1.94 0.00 1.94 6.22 1. oftalmoskopij (direct) in both eyes, the result of the evaluation procedure 0.81 0.00 0.81 6.23 1. oftalmoskopij (indirect) in both eyes, the result of the evaluation procedure 1 0.71 0.00 0.71 6.24. binocular indirect oftalmoskopij, graphical display of the results of the procedure 1.84 0.00 1.84 6.25 1. corneal staining with fluorescīn of both eyes 1 procedure removal foreign body 0.61 0.00 0.61 6.26. from eye bags konjuktīv or mechanical Eyelash hair removal procedure 1, 6.27. foreign matter removal 0.87 0.00 0.87 of cornea
1. tear the 2.73 0.00 2.73 procedure 6.28 channel rinsing one side 1 procedure 1.94 0.00 1.94 6.29. determination of FOV 1 procedure at 6.30. gaps to 1.06 0.00 1.06 eyes and movement evaluation procedure 2.02 0.00 2.02 7 1. physical medicīna1 7.1. electrophoresis procedure 2.09 0.00 2.09 7.2 fonoforēz 1 1 procedure 2.95 0.00 2.95 7.3. diadinamisk power (DD) therapy 1 procedure 1.83 0.00 1.83 7.4. diadinamisk power (DD) forēz 1 procedure for sinusoidal modulated 2.35 0.00 2.35 7.5. current (SMS) forēz 1 procedure 7.6. darsonvalizācij 1 2.35 0.00 2.35 procedure 1.85 0.00 1.85 7.7 induktotermij 7.8 1 procedure 1.54 0.00 1.54. ultraīsviļņ therapy, centimeters or decimetre wave therapy-wave therapy 1 procedure 1.24 0.00 1.24 7.9. ultrasonic therapy 1 procedure aerosolterapij 2.79 0.00 2.79 7.10 (inhalation) 1 procedure 1.77 0.00 1.77 7.11. ultraviolet irradiation of 1 procedure 1.81 0.00 1.81 7.12. magnetolāzer laser therapy or therapy procedure 1. paraffin-ozokerite 2.45 0.00 2.45 7.13 therapy procedure 3.16 0.00 3.16 7.14. amplipulsterapij 1 of 1 7.15. the low-frequency 1.20 0.00 1.20 procedure magnetoterapij procedure 1 0.82 0.00 0.82 7.16. magnetolāzer therapy 1 procedure 1.90 0.00 1.90 7.17. ultrasonic spray 1 procedure 1.00 0.00 1.00 7.18. head massage 1 procedure 1.50 0.00 1.50 7.19. the collar zone massage 1 procedure 4.50 0.00 4.50 7.20. arm and shoulder area massage 1 procedure 5.50 0.00 5.50 7.21. chest massage 1 procedure 3.50 0.00 3.50 7.22. back massage (C2-S5) 1 procedure 6.00 0.00 6.00 7.23. abdominal massage 1 procedure 1.50
0.00 1.50 7.24. back-cross part 1 procedure of massage back neck 2.00 0.00 2.00 7.25.-part 1 of breast massage procedure 4.00 0.00 4.00 7.26. back breast massage part 1 procedure in principle established 2.50 0.00 2.50. the legs and hip area massage 1 procedure 3.00 0.00 3.00 7.28. General massage (for babies and children up to a year old) 1 procedure 2.50 0.00 2.50 7.29. General massage (1-3 years old children) 1 procedure 7:30. General 3.00 0.00 3.00 massage (7-14 years old children)
1 procedure Fizioterapija1 8 8.1 patient 4.50 0.00 4.50 activation after surgical diseases (30 min), 1 procedure pulmonoloģisk of patients 3.15 0.00 3.15 8.2 physiotherapy individually (50 min) 1 procedure 3.15 0.00 3.15 8.3. postural drainage, massage, breathing exercises dynamically to individual (60 min) 1 procedure a patient first 4.00 0.00 4.00 8.4. investigation and functional status determination, rehabilitation programmes dialling procedure 1 4.76 0.00 4.76 8.5. patient was as needed but at least after 10 days, and finally treatment course 1 procedure 8.6. patient 2.00 0.00 2.00 functional investigation, carried out by a physiotherapist 1 3.56 0.00 3.56 8.7. kinezoterapij procedure for patients with the support-system of movement or diseases of the nervous system (45 min) 1 procedure 4.00 0.00 4.00 8.8. kinezoterapij patients with the support-system of movement or diseases of the nervous system (2 to 5 people in a group of 50 min) 1 procedure 2.00 0.00 2.00 9. Other manipulation and procedūras1 9.1. injection skin 1 injection 0.52 0.00
hypodermic injection of 9.2 0.52 1 injection 0.52 0.00 0.52 9.3. injection muscle 1 injection 0.52 0.00 0.52 9.4. injection vein 1 injection 1.56 0.00 1.56 9.5. infusion vein 1 procedure 1.92 0.00 1.92 9.6. blood sampling of vein 1 injection of 1 1.04 0.00 1.04 9.7. vakutainer injection capillary blood 0.16 0.00 0.16 9.8. check-out with a 1 mikrotainer study blood pickup 0.45 0.00 0.45 9.9. in a closed system, 2 vials 1 study 0.65 0.00 0.65 9.10. stitch finger 1 procedure-0.36
0.00 0.36 9.11. arterial blood pressure of 1 procedure noteikšam 0.60 0.00 0.60 II. Public services that are provided to a person without a family doctor or specialist referral outpatient or inpatient investigation and treatment 10. Health care outpatient counseling in nodaļā1 10.1. Professor (first inspection) 1 consultation consultation 35.00 0.00 35.00 10.2. Professor (repeat visitation) 1 consultation consultation 20.00 0.00 20.00 10.3. Assistant Professor (first inspection) 1 consultation consultation 25.00 0.00 25.00 10.4. Assistant Professor (repeat visitation) 1 consultation consultation 15.00 0.00 15.00 10.5 infektolog tropical disease (at the time) 1 consultation 8.00 0.00 8.00 10.6. infektolog consultation tropical disease (out of time) 1 consultation radiologist advice 10.7.10.00 0.00 10.00 1 study 4.00 0.00 4.00 10.8 preventive inspection 1 ophthalmologist study 7.85 0.00 7.85 10.9. otorinolaringolog preventive inspection 1 the study of occupational disease the doctor looking at 6.30 0.00 6.30 10.10 1 study 6.00 0.00 6.00 10.11.-certified infektolog, therapist Pediatrics, dermatovenerolog,, ftiziopneimonolog, pneimonolog, traumatolog, ortopēd, urolog, psychiatrist, gynecologist, surgeon, thoracic surgeon, neurologist, psychotherapist, otorin hepatolog, the laringolog, oftamolog consulting (first inspection) (1) certified the 10.12.15.00 0.00 15.00 advice infektolog, therapist, Pediatrics, dermatovenerolog, ftiziopneimonolog, pneimonolog, traumatolog, ortopēd, urolog, psychiatrist, gynecologist, surgeon, thoracic surgeon, neurologist, psychotherapist, otorin hepatolog, the laringolog, oftamolog consulting (re view) 1 consultation dermatologist advice 5.00 0.00 5.00 10.13. home (out of hours) 1 study 30.00 0.00 30.00 11.11.1. Otorinolaringoloģija1 nasal bleeding stopping by irritants and/or tamponād with elektrokauter of engagement
1 procedure tamponād-10.10 0.00 10.10 11.2. nose from the front 1 procedure 6.49 0.00 6.49 11.3. pull out foreign bodies in the nose 1 procedure 9.80 0.00 9.80 11.4. Haimor cavity puncture the rinsing and medication infusion 1 procedure 3.63 0.00 3.63 11.5. medication administration of larynx 1 procedure 3.05 0.00 3.05 11.6. sulphur removal procedure 1 Cork 1.90 0.00 1.90 7.3. removal of foreign bodies from the hearing of 1 procedure go 2.29 0.00 2.29 11.8. medication administration hearing passage 1 procedure 2.19 0.00 2.19 7.4. unbroken, the incision procedure 1 enter 2.59 0.00 2.59 11.10. medicines the drum cavity 1 procedure 2.05 0.00 2.05 11.11. hearing test procedure 1 1.75 0.00 1.75 11.12. hearing threshold test (audiometrij) 1 procedure 11.13. virssliekšņ tests 3.75 0.00 3.75 1 3.77 0.00 3.77 11.14. timpanometrij procedure procedure 1. Uroloģija1.12 cistoskopij 4.65 0.00 4.65 12.1, including uretroskopij and/or biopsy procedure 1 14.86 0.00 14.86 12.2. Women 1 procedure bužēšan urethra 2.80 0.00 2.80 12.3. male urethra 1 procedure 3.90 0.00 bužēšan
3.90 12.4 bladder katetrizācij using a single catheter procedure 1 2.30 0.00 2.30 12.5. bladder flushing, katetrizācij with medication instilācij. Continuous catheter insertion procedure 1 4.57 0.00 4.57 12.6. bladder flush when inserted into a permanent catheter procedure 1 2.11 0.00 2.11 12.7. Prostate Massage 1 procedure Ķirurģija1 13 13.1.3.60 0.00 3.60 wound primary finish 1 procedure 3.63 0.00 3.63 13.2 primary surgical wounds finish, including cutting and sealing procedure 1 remove foreign bodies 8.95 0.00 8.95 13.3 from wounds 1 procedure for removal of thread 4.07 0.00 4.07 13.4 1 procedure 1.78 0.00 1.78 13.5 medication administration , if you wash the cavity abscess and strutojoš wounds 1 procedure 3.74 0.00 3.74 13.6 superficial tissue puncture biopsy procedure 1 5.39 0.00 5.39 8.5. loose the bone, muscles, lymph node biopsy surgery procedure 30.28 0.00 30.28 13.8 1. superficial incision with drainage procedure 1 11.72 0.00 11.72 13.9. local benign cutaneous and subcutaneous formations of ekstirpācij and superficial tissue biopsy surgery procedure 1 24.22 0.00 24.22 13.10. local benign cutaneous and subcutaneous formations of ekstirpācij and superficial tissue biopsy ambulatory procedure 1
13.11.15.00 0.00 15.00 injection procedure for wrist 1 2.05 0.00 2.05 13.12. bandage 1 procedure 0.50 0.00 0.50 13.13. abdominal cavity puncture room 1 procedure 4.92 0.00 4.92 pleural cavity puncture 13.14. using single-use Kit 1 procedure 8.65 0.00 8.65 1.15 p.m.. lumbar puncture procedure 1 5.48 0.00 5.48 13.16. bone marrow puncture, using single-use Kit 1 procedure 18.00 0.00 18.00 13.17. Joint puncture procedure 4.00 0.00 4.00 1 13.18.

spine blockade with drugs injected into the spinal canal 1 procedure of thoracic 4.45 0.00 4.45 13.19. conventional (open torakomij) operation operation 1 300.00 0.00 300.00 13.20. videotorakoskopisk (watt) operation operation 1 350.00 0.00 350.00 13.21. torakotomij thoracic vertebrae, resection of spinal decompression, front spondilodēz 1 300.00 0.00 300.00 13.22. operation of lumbar vertebra lumbotomij resection, decompression, the front operation 1 300.00 0.00 300.00 spondilodēz 13.23. bonus for the mechanical application of the linear seamstress operation 1 200.00 0.00 200.00 13.24. griezējšuvēj use of premium 1 operation 215.00
0.00 215.00 13.25. bonus on griezējšuvēj in the use of endoscopic surgery 325.00 0.00 325.00 13.26.1 bonus on the net Prolen (12 x 12 cm) use 1 piece 40.00 0.00 40.00 13.27. bonus on the net Proceed pretsaaugum (12 x 12 cm) use 1 piece 290.00 0.00 290.00 13.28. supplement for cement use metilmetakrilāt chest wall prosthetic reinforcement 1 piece 200.00 0.00 200.00 13.29. the premium for Tachosil hemostātisk līmplēv in (4.8 x 9.5 cm) use 1 piece 165.00 0.00 165.00 13.30. Pleur-premium Seal application of tissue glue, 1 piece 335.00 0.00 335.00 13.31. bonus on one Preclud of the pericardial membrane (12 x 12 cm) use 1 piece 395.00 0.00 395.00 13.32. the premium for one Dualmesh diaphragms replacements (20 x 30 cm) use 1 piece 1600.00 0.00 1600.00 42.86. supplement for bone collagen matrices to use Osteovi 1 piece 16.50 0.00 16.50 13.34. supplement for bone substitute to use Osteose 1 piece 231.00 0.00 231.00 13.35. supplement for use in the hemostātisk sponge Spongostan 1 piece 9.00 0.00 9.00 13.36.
Supplement for anaesthesia and anaesthesia in thoracic surgery (first hour) 1 hour 180.00 0.00 180.00 13.37. supplement for anaesthesia and anaesthesia in thoracic surgery (starting from the second hour of each next hour) 1 hour 35.00 0.00 35.00 13.38. supplement for the use of the catheter in epidurāl pain management for 1 piece respirator adequate 25.00 0.00 25.00 13.39. piekļaušan test (fit test) 1 piece 4.00 0.00 4.00 Ginekoloģija1 14.1 14. gynecologist birth, preventive inspection 1 study 7.55 0.00 7.55 14.2. uterine spiral procedure 1 enter 3.30 0.00 3.30 14.3. uterine spiral removal procedure 1 2.04 0.00 2.04 14.4. investigation of mammary gland 1 procedure onkocitoloģisk-0.80 0.00 0.80 14.5. check-out of 1 swab procedure swab sampling of 0.86 0.00 0.86 14.6. Sti Diagnostics procedure 1 1.22 0.00 1.22 14.7. the vagina wall and cervix biopsy procedure 1 12.47 0.00 12.47 14.8. uterus aspiration and cytology investigation of preparation procedure 1 3.23 0.00 3.23
9.3. the uterine mass correction with rings 1 procedure for glands Bartolin 2.94 0.00 2.94 14.10. incision procedure 14.42 0.00 14.42 14.11 1. cervical canal polip removal procedure 1 11.67 0.00 11.67 14.12. cervical dilation and abrāzij channel in the diagnostic investigation procedure 1 10.64 0.00 10.64 14.13. abrāzij uterus 1 procedure 10.46 0.00 10.46 14.14. pussy back arches puncture procedure 1 5.53 0.00 5.53 14.15. gynecological investigation with single-use mirror 1 procedure 15.1.20 0.00 1.20 laboratory clinical studies izmeklējumi1 15.1.
 
 
 
 
15.1.1. investigation of blood leukocyte 15.1.1.1. (adding the camera) 1 0.33 0.00 0.33 15.1.1.2. retikulocīt study (manually) 1 study 0.67 0.00 0.67 15.1.1.3. platelets (manually) 1 study 0.55 0.00 0.55 15.1.1.4. erythrocyte sink rate (EG) 1 study 0.47 0.00 0.47 15.1.1.5. leukocyte formula and erythrocyte morphology study 0.83 0.00 0.83 15.1.1.6.1 red vilkēd (LED) study of cell 1 2.22 0.00 2.22 15.1.1.7. blood test with a three-part Blood analyser 1 differentiating study of automated retikulocīt 1.07 0.00 1.07 15.1.1.8. investigations with haematology analyser
1 study 3.28 0.00 3.28 15.1.1.9. blood analysis with five-part Blood analyser 1 discriminatory study 15.1.2. investigation of urine 2.05 0.00 2.05 15.1.2.1. protein (quantitative) study 1 0.52 0.00 0.52 15.1.2.2. quantitative sediment microscopy 1 study 0.78 0.00 0.78 15.1.2.3. urine analysis with strip (environmental level (pH), proteins, sugar, acetone, bilirubin, urobilinogēn, blood) study 1 15.1.3 0.61 0.00 0.61. likvor clinical investigation study 1.68 0.00 1.68 15.1.4.1 sputum examination 15.1.4.1. clinical sputum analysis 1 study 1.08 0.00 1.08 15.1.4.2.
mikobaktērij bakterioskopisk of investigation 1 study 1.41 0.00 1.41 15.1.5. faecal examination 15.1.5.1. koprogramm 1 the examination of latent blood 1.08 0.00 1.08 15.1.5.2.1 study 0.31 0.00 0.31 15.1.5.3. bile pigments 1 study 0.40 0.00 0.40 15.1.5.4. hidden blood with teststrēmel (imūnhromatogrāfij) 1 study of serous cavity 1.10 0.00 1.10 15.1.6. cyst fluid and clinical analysis in study 1 1.57 0.00 1.57 15.1.7. cytological studies on swab from 15.1.7.1. onkocitoloģisk cervical canal (1 product) and back arches 1 study 2.10 0.00 2.10 15.1.7.2. cytological studies from the cervical canal (3 products) 1 study 15.1.7.3. cytological studies 2.92 0.00 2.92 out of the abdominal cavity, pleural and Douglas, the uterine cavity (3 products) 1 study 5.00 0.00 5.00 15.1.7.4. urine or bladder washings for cytology investigation (5 formulations) 1 study 3.86 0.00 3.86 15.1.7.5. sputum cytology investigation (3 products) 1 study 3.67 0.00 3.67 15.2 15.2.1. biochemical studies of blood bilirubin in the investigation 15.2.1.1. Study Group 1, 0.68 0.00 0.68 15.2.1.2. alanīnaminotransferāz 1 the examination 0.58 0.00 0.58 15.2.1.3. aspartātaminotransferāz 1 the examination 0.58 0.00 0.58 15.2.1.4. alkaline phosphatase 1 study 0.58 0.00 0.58 15.2.1.5. Alpha-1 amilāz study 15.2.1.6.1 gammaglutamiltransferāz 1.08 0.00 1.08 study 0.73 0.00 0.73 15.2.1.7.1 kreatīnkināz study 15.2.1.8 0.73 0.00 0.73. urea (bun) 1 study 15.2.1.9 0.72 0.00 0.72. creatinine 1 study 0.64 0.00 0.64 uric acid study 15.2.1.10.1 15.2.1.11. protein 0.70 0.00 0.70 (total) 1 study 0.50 0.00 0.50 15.2.1.12.
albumin 1 study 0.57 0.00 0.57 15.2.1.13. protein fractions 1 study 2.25 0.00 2.25 blood glucose 15.2.1.14.1.15.2.1.15 glucose 0.50 0.00 0.50 a study load test 1 study 1.67 0.00 1.67 15.2.1.16. total cholesterol 1 study 15.2.1.17 0.53 0.00 0.53. triglycerides study 0.85 0.00 0.85 15.2.1.18.1 C-reactive protein (quantitative) study 1.15 0.00 1.15 15.2.1.19.1 ferritīn 1 15.2.1.20 antistreptolizīn of study 3.20 0.00 3.20.-0 (high quality) 1 study 15.2.1.21. determination of ethanol 1.10 0.00 1.10 enzymatic study 3.16 0.00 3.16 15.2.1.22 1.
potassium 1 study 0.64 0.00 0.64 15.2.1.23. sodium 1 study 15.2.1.24. calcium 0.64 0.00 0.64 1 study 0.61 0.00 0.61. iron 1 15.2.1.25 study 15.2.1.26. iron binding 0.61 0.00 0.61 ability study 1.54 0.00 1.54 15.2.1.27. copper 1 blood 1 study 1.68 0.00 1.68 15.2.1.28. free (FT4) 1 tiroksīn study 15.2.1.29. free trijodtironīn 3.03 0.00 3.03 (FT3) 1 study the hormone 15.2.1.30. tireotrop 3.03 0.00 3.03 (TSH) 1 study 2.93 0.00 2.93 reduced glutathione 15.2.1.31.1 study 5.70 0.00 5.70 15.2.1.32.
rheumatoid factor (high quality) 1 study 0.94 0.00 0.94.15.2.1.33 high density lipoproteins (HDL) cholesterol study 1.20 0.00 1.20 1.15.2.1.34 low density lipoproteins (LDL) cholesterol study 1.65 0.00 1.65 15.2.1.35. apolipoproteīn 1 A1 1 study. B apolipoproteīn 15.2.1.36 1 1.90 0.00 1.90 study 15.2.1.37. transferīn soluble 1.90 0.00 1.90 receptor 1 study. cardiac Troponin 15.2.1.38 4.38 0.00 4.38 the T (acute myocardial infarction Express) 1 study 4.72 0.00 4.72 15.2.1.39.1 15.2.1.40 Myoglobin study 3.40 0.00 3.40. insulin 1 study 3.07
15.2.1.41 0.00 3.07. hyaluronic acid 1 study 15.2.1.42.18 citokeratīn 8.72 0.00 8.72 (CK 18 neo-epitopes) 1 study 6.27 0.00 6.27 cytochrome c 15.2.1.43.1 15.2.1.44. endotoxin 8.77 0.00 8.77 study core antibody (quantitative) 1 study of nitrate/nitrite 6.30 0.00 6.30 15.2.1.45. quantitative study 5.42 0.00 5.42 15.2.1.46 1. blood gas and environmental level (pH) analysis 1 study serum 12.25 0.00 12.25 15.2.1.47. (plasma) getting 1 study 0.20 0.00 0.20 15.2.1.48. magnesium 1 study 1.20 0.00 1.20 15.2.1.49.1 laktātdehidrogenāz study
15.2.1.50 determination of immunoglobulin IgG 1.10 0.00 1.10.1 the study of immunoglobulin Ig 2.00 0.00 2.00 15.2.1.51. Discovery 1 study of immunoglobulins IgM determination 2.10 0.00 2.10 15.2.1.52.1 15.2.1.53. ceruloplazmīn 2.20 0.00 2.20 study 1 study is 2.37

15.2.1.54 0.00 2.37. ammonia 1 study 15.2.1.55.1 mikroalbumīn 2.20 0.00 2.20 study 2.34 0.00 2.34 15.2.1.56. glikohemoglobīn (HbA1c) 1 study likvor the study 3.53 0.00 3.53 15.2.2.15.2.2.1. chlorides 1 study 0.62 0.00 0.62 15.2.2.2. protein (quantitative) study 1 0.52 0.00 0.52 15.2.2.3. glucose (quantitative) study 1 investigated 0.50 0.00 0.50 15.2.3 punktāt (protein (total)) 1 study imūnhematoloģij tests 0.50 0.00 0.50 15.2.4.15.2.4.1. determination of blood group ABO system with planes method (dubultreakcij) (A and B antigen with direct reaction, anti-A and anti-B antibodies with the inverse reaction) 1 study 1.08 0.00 1.08 15.2.4.2. Rhesus (Rh (D)) home by plane (with two reagents) study 1 1.14 0.00 1.14 15.2.4.3. Rhesus (Rh (D)) geltehnik in the home setting (with a single reagent) 1 study not full antieritrocitār 1.20 0.00 1.20 15.2.4.4. antibody screening geltehnik (ID card List/Coomb) 1 study 2.23 0.00 2.23 15.2.4.5. determination of blood group ABO system with planes method (direct response) (A and B antigen with direct response)
1 the study of blood group 0.86 0.00 0.86 15.2.4.6. determination of ABO and Rh system in geltehnik (A and B antigen detection by direct reaction, anti-A and anti-B antibodies with the inverse reaction, D Antigen) 1 study 2.76 0.00 2.76 15.2.4.7. Rh system phenotype (CcE) and the determination of the Kell geltehnik 1 study of the recipient and the donor 4.28 0.00 4.28 15.2.4.8. blood compatibility test lab of the individual (both the , Rh and other systems-geltehnik) 1 study 4.58 0.00 4.58 15.2.4.9. test-direct anti-human globulin (data) geltehnik (ID card List/Coomb) 1 study koaguloģij tests 1.23 0.00 1.23 15.2.5.15.2.5.1. protrombīn index (INR) 1 study the activated partial 0.96 0.00 0.96 15.2.5.2. tromboplastīn time (APTL) 1 study 1.09 0.00 1.09 15.2.5.3. IX 1 study 15.2.5.4 Thrombin time 1.09 0.00 1.09.1 the study urine investigation 15.2.6 1.03 0.00 1.03.15.2.6.1. glukuronīd to study 15.2.6.2 in urine 1 5.54 0.00 5.54. protein (quantitative) study 1 0.52
15.2.6.3 0.00 0.52. glucose (quantitative) study 1 0.50 0.00 0.50 15.2.6.4. Alpha-1 amilāz study 15.2.6.5. iron 1.08 0.00 1.08 1 study 15.2.6.6. calcium 0.61 0.00 0.61 1 study. 15.2.6.7 urea 0.61 0.00 0.61 (bun) 1 study 15.2.6.8 0.72 0.00 0.72. creatinine 1 study 0.64 0.00 0.64 15.2.6.9. uric acid study 1. determination of ethanol 15.2.6.10 0.70 0.00 0.70 enzymatically 1 study 3.16 0.00 3.16 15.2.6.11. drugs and their derivatives ekspresdiagnostik test (panel of four substances) 1 study 2.37 0.00 2.37 drug 15.2.6.12. substances and their derivatives ekspresdiagnostik test (panel of eight substances) 1 3.73 0.00 3.73 15.2.7. testing the study with dry chemistry analyser REFLOTRON 15.2.7.1 IV. determination of cholesterol by dry chemistry analyser 1 study IV 1.16 0.00 1.16 REFLOTRON 15.2.7.2. determination of bilirubin with dry chemistry analyser REFLOTRON IV 1 study 15.2.7.3. alanīnaminotransferāz 1.16 0.00 1.16 (AL) with dry chemistry analyser 1 study IV REFLOTRON 1.16 0.00 1.16. aspartātaminotransferāz 15.2.7.4 (S) with dry chemistry analyser REFLOTRON IV 1 study 1.16 0.00 1.16
15.2.7.5. determination of triglycerides with dry chemistry analyser 1 study IV REFLOTRON 1.35 0.00 1.35 15.2.7.6. pankreātisk determination of amylase by dry chemistry analyser 1 study IV 1.63 0.00 1.63 REFLOTRON 15.2.7.7. determination of glucose by dry chemistry analyser 1 study IV REFLOTRON 1.07 0.00 1.07.15.2.7.8 high density lipoproteins (HDL)-cholesterol determination by dry chemistry analyser REFLOTRON 1 study 1.43 0.00 1.43 15.2.7.9. urea (bun) with dry chemistry analyser 1 study IV REFLOTRON 1.33 0.00 1.33 15.2.7.10 creatinine concentration. determination by dry chemical analyser 1 study IV REFLOTRON 1.25 0.00 1.25.15.2.7.11 determination of alpha-amylase with a dry chemical analyser 1 study IV 1.56 0.00 1.56 REFLOTRON 15.2.7.12. determination of potassium with dry chemistry analyser REFLOTRON 1.37 0.00 1.37 15.2.7.13. IV study 1 gammaglutamīntransferāz (GG) activity detection with dry chemistry analyser 1 study IV REFLOTRON 1.17 0.00 1.17 15.2.7.14. alkaline phosphatase activity detection with dry chemistry analyser 1 study IV 1.32 0.00 1.32 REFLOTRON 15.2.7.15. kreatīnkināz activity determination by dry chemistry analyser REFLOTRON IV
1 study 1.71 0.00 1.71 parasitological studies 15.3 15.3.1. blood parasite (malaria, filariidoz) thick drops (ARV series) 1 study 15.3.2. malaria plazmodij 6.00 0.00 6.00 blood smear (preparation) 1 Plasmodi 15.3.3 5.52 0.00 5.52. study of Ag in the blood (imūnhromatogrāfij) study 1 3.83 0.00 3.83 15.3.4. investigation for enterobioz with adhesive tape method 1 study by 0.76 0.00 0.76 15.3.5 Pneumocyst jiroveci (carini) Ag (IF)-Pneumocyst by jiroveci (carini) Antigen with indirect imūnfluorescenc microscopy study of 1 Cryptosporidium Ag 10.08 0.00 10.08 15.3.6 the faeces with (ELISA), Cryptosporidium Antigen with imūnfermentatīv response 1 3.86 0.00 3.86 15.3.7. lamblij study and determination of helminth bile in preparation for native and sediment (three servings) 1 study 2.79 0.00 2.79 15.3.8. protozoa and helminth cyst investigation with enrichment (concentration) method 1 study helmint and 2.67 0.00 2.67 15.3.9. fragment detection 1 study of intestinal protozoa 1.34 0.00 1.34 15.3.10. parasite detection natīv in study preparation 1 1.47 0.00 1.47 15.3.11. Anti-Toxocar-Canis IgG (ELISA) immunoglobulin G antibody discovery class against the larvae of dogs cērmj 1 study 3.06 0.00 3.06 15.3.12. Anti-Trichinella spiralis (ELISA) immunoglobulin IgG-class G antibodies against Trichinella examination 1 15.3.13 3.06 0.00 3.06. Echinococcus anti-IgG (ELISA) species: immunoglobulin G antibodies to the class of ehinokok species (e. granulos, e. multilocularis) 1 study 3.06 0.00 3.06 15.3.14. Echinococcus granulosus of anti-IH-HA antibody reaction to the unicameral ehinokok 1 the examination of lambli 6.07 0.00 6.07.15.3.15 Compatible (Ag faeces) (ELISA)-lamblij with imūnfermentatīv of Antigen reaction 1 study 3.16 0.00 3.16 15.3.16.
Entamoeb-anti-hystolitic-IH-HA antibody reaction to the hystolitic Entamoeb (the dysentery Amoeba) 1 study of Entamoeb hystolitic of 7.07 0.00 7.07 15.3.17. Ag in faeces (ELISA) – the Amoeba dysentery Antigen with imūnfermentatīv response 1 study 3.86 0.00 3.86 15.3.18. Anti-IgG (ELISA) of Taenia-immunoglobulin G antibodies against the class of the pig tapeworm larvae 1 study of Cysticercos WB 15.3.19 3.16 0.00 3.16. cisticerk immunoglobulin G IgG-class antibody validation by Western blot reaction 1 study of Toxocar WB IgG 31.10 0.00 31.10 15.3.20. – toksokar immunoglobulin G class antibody validation by Western blot reaction 1 study 15.3.21 Trichinella WB IgG 27.50 0.00 27.50.-Trichinella antibodies of immunoglobulin G class approval by Western blot reaction 1 study of Echinoccoc WB IgG 31.10 0.00 31.10 15.3.22. – ehinokok immunoglobulin G antibody validation class with Western blot reaction 1 study 33.10 0.00 33.10 15.4. sexually transmitted skin disease investigations and 15.4.1. Chlamydia trachomatis Antigen (IFA) – Chlamydia trachomatis Antigen with indirect imūnfluorescenc method 1 study 3.92 0.00 3.92 15.4.2. Chlamydia trachomatis Antigen (IFA)-Chlamydia trachomatis Antigen with indirect imūnfluorescenc method for women (2 places), 1 study 7.84 0.00 7.84 15.4.3. Chlamydia trachomatis Antigen (ELISA) – Chlamydia trachomatis Antigen with imūnfermentatīv response 1 study 6.20 0.00 6.20 15.4.4. Chlamydia trachomatis Antigen confirmatory test (ELISA) – Chlamydia trachomatis Antigen approval with imūnfermentatīv response 1 study 9.90 0.00 9.90 15.4.5. Chlamydia trachomatis anti-IGA (ELISA)-IGA antibodies to Chlamydia trachomatis detection with imūnfermentatīv response 1 study 3.48 0.00 3.48 15.4.6. Anti-Chlamydia trachomatis IgG-IgG antibody (ELISA) against Chlamydia trachomatis the reaction of imūnfermentatīv with 1 study 3.48 0.00 3.48 15.4.7. Chlamydia trachomatis rRNA discovery 1 study 12.90 0.00 12.90 15.4.8. Chlamydia trachomatis DNA detection by polymerase chain reaction (PCR) 1 study of gonorrhoea 19.58 0.00 19.58 15.4.9. Not isseri the determination of the study 1 rRNA 12.90 0.00 12.90 15.4.10. Chlamydia trachomatis rRNA and isseri rRNA of gonorrhoea a discovery 1 study 13.90 0.00 13.90 15.4.11.

Gonorrhoea Gonorrhoea is not isseri the determination of DNA by polymerase chain reaction (PCR) 1 study of chlamydia at 19.58 0.00 19.58 15.4.12. trachomatis DNA and the DNA of gonorrhoea isseri by polymerase chain reaction (PCR) 1 study of bakterioskopij films 29.45 0.00 29.45 15.4.13. microflora and the determination of the 1 ST study 1.86 0.00 1.86 15.4.14. syphilis Diagnostics-(demonstration of Treponema pallidum) HA (TPH) 1 study 1.38 0.00 1.38 15.4.15. syphilis Diagnostics-(demonstration of Treponema pallidum) HA (TPH) ANOTHER 1 study 4.14 0.00 4.14 15.4.16. syphilis Diagnostics-(demonstration of Treponema pallidum) HA response (TPH) by titration 1 study of Treponema pallidum 3.06 0.00 3.06 15.4.17. dark field microscopy 1 study 1.65 0.00 1.65 15.4.18. syphilis Diagnostics-reagīn of precipitation (RPR) 1 study 15.4.19. syphilis Diagnostics 0.85 0.00 0.85 – reagīn precipitin reaction (RPR) with titration 1 study 15.4.20. IF both 1.85 0.00 1.85 anti-IgM IgM Treponema pallidum antibody of against-demonstration of Treponema pallidum by immunofluorescence microscopy study of 15.4.21.1 3.73 0.00 3.73 IF both anti-demonstration of Treponema pallidum antibodies-antibodies against a demonstration of Treponema pallidum by immunofluorescence Microscopy study of 1 3.73 0.00 3.73.15.4.22 anti-demonstration of Treponema pallidum IgM IgM antibody (ELISA) – against the demonstration of Treponema pallidum by imūnfermentatīv response 1 study 7.70 0.00 7.70.15.4.23 anti-demonstration of Treponema pallidum antibodies-antibodies against a demonstration of Treponema pallidum by imūnfermentatīv response 1 study 15.4.24 antibodies against IgG 5.28 0.00 5.28. Demonstration of Treponema pallidum by immunoblot assay validation study of 1.15.4.25 antibody against 21.89 0.00 21.89 IgM Treponema pallidum of the approval by the immunoblot assay 1 study 21.89 0.00 21.89 plating 15.4.26. ureaplazm detection of mycoplasmas and 1 study 7.48 0.00
7.48 15.4.27. detection of gonococcal 1 plating study syphilis Diagnostics 7.37 0.00 7.37 15.4.28. – reagīn precipitin reaction (RPR)-2.55 0.00 2.55 15.4.29 ANOTHER study 1. sexually transmitted diseases (STDs) OTHER film 1 study 15.4.30. certificate of 5.58 0.00 5.58 syphilis: reagīn precipitin reaction (RPR) and of HA Trepanem pallidum (TPH) 1 study 15.4.31. certificate of 2.73 0.00 2.73 syphilis with duplicate: reagīn of precipitation (RPR) and of HA Trepanem pallidum (TPH) with a study of the replica 1 15.4.32 health card 3.23 0.00 3.23. intīmpakalpojum providers 1 study prostate eksprimāt 1.20 0.00 1.20 15.4.33. investigation 1 study material pickup 15.4.34 2.80 0.00 2.80. pathogenic skin, nails, hair or for the determination of dziedzerērc fungi from 1 focus 1 study material pickup 15.4.35 0.36 0.00 0.36. pathogenic skin, nails, hair or for the determination of dziedzerērc fungi from multiple foci (2 – 3 foci) 1 study material (0.60 0.00 0.60 15.4.36. nails, skin , hair) the investigation for the determination of each fungal outbreak 1 study material 2.28 0.00 2.28.15.4.37 (nails, skin, hair) for the detection of fungal investigation for each outbreak, ANOTHER 1 study pathogen inoculum 8.64 8.64 15.4.38. skin, hair, nail fungus discovery 1 study 15.4.39 demodekoz 6.00 0.00 6.00. investigation of study 1 2.58 0.00 2.58 15.4.40. investigation for the determination of demodekoz (1 hour) 1 study 7.74 0.00 7.74 15.4.41. scabbers ticks discovery 1 study 3.12 0.00 3.12 15.4.42. scabbers ticks (1 hour) 1 study 9.36 0.00
15.4.43 Mycoplasma or ureaplazm 9.36. identification and determination of sensitivity to antibiotics 1 study 9.02 0.00 9.02 15.5. hepatitis diagnostic 15.5.1. Anti-HAV: antibody (ELISA) against viral hepatitis A through study of the imūnfermentatīv reaction 1 3.38 0.00 3.38 15.5.2. Anti HAV IgM (ELISA) immunoglobulin M antibodies against viral hepatitis in class A with imūnfermentatīv response 1 study 3.95 0.00 3.95 15.5.3. have Ag (ELISA) – viral hepatitis A Antigen with imūnfermentatīv response 1 study. Hbs Ag 15.5.4 4.47 0.00 4.47 (ELISA) – viral hepatitis B surface antigen the reaction of 1 with imūnfermentatīv study. Hbs Ag confirmatory 15.5.5 1.80 0.00 1.80 (ELISA) – viral hepatitis B surface antigen positive test 1 study 5.31 0.00 5.31 15.5.6. Anti-HBS quantitative (ELISA) – antibody against hepatitis B virus in the tatīv determination by quantum imūnfermentatīv response 1 study 4.88 0.00 4.88 15.5.7. Anti-HBc antibody (ELISA) against viral hepatitis B core Antigen with imūnfermentatīv reaction study 3.61 0.00 3.61 15.5.8 1. Anti-HBc IgM (ELISA) immunoglobulin M antibodies against viral hepatitis of class B core Antigen with imūnfermentatīv response 1 study 4.19
15.5.9 0.00 4.19. Hbe Ag (ELISA) – viral hepatitis B E Antigen with imūnfermentatīv response 1 study 5.10 0.00 5.10 15.5.10. Anti-HBE antibody (ELISA) against viral hepatitis B E Antigen with imūnfermentatīv response 1 study 5.10 0.00 5.10.15.5.11 anti-HCV (ELISA) – antibody against viral hepatitis C with imūnfermentatīv response 1 study 4.15 0.00 4.15.15.5.12 anti-HCV positive test (WB) – antibody against viral hepatitis C approval by Western blot reaction in study 1. HCV RNA 27.93 0.00 27.93 15.5.13 (PCR) – determination of viral hepatitis C ribonukleīnskāb with polymerase chain reaction study 36.82 0.00 36.82 15.5.14.1 HD Ag (ELISA)-Hepatitis delta virus Antigen with imūnfermentatīv response 1 study 3.24 0.00 3.24.15.5.15 anti-HD (ELISA) immunoglobulin IgM-class antibodies against M Hepatitis delta virus detection with imūnfermentatīv response 1 study 3.80 0.00 3.80 15.5.16. AFP (ELISA)-alpha-fetoproteīn detection with imūnfermentatīv response 1 study HBS Ag 4.18 0.00 4.18 15.5.17. Other (ELISA) – viral hepatitis B surface antigen detection with imūnfermentatīv quick response two hours 1 study 5.54
0.00 5.54 anti-HAV IgM 15.5.18. Other (ELISA) immunoglobulin M antibodies against viral hepatitis class A quick determination by imūnfermentatīv response two hours 1 study 9.28 0.00 9.28.15.5.19 anti-HBc (ELISA) – Other antibodies against viral hepatitis B core Antigen two hours 1 study 9.12 0.00 9.12.15.5.20 anti-HCV (ELISA) – Other antibodies against viral hepatitis C quick determination by imūnfermentatīv reaction within two hours of study 15.5.21.1 HBS Ag 10.34 0.00 10.34 certificate (ELISA) – viral hepatitis B surface antigen with imūnfermentatīv reaction
1 study 15.5.22. Hbs Ag 5.18 0.00 5.18 certificate (ELISA) – viral hepatitis B surface antigen with imūnfermentatīv response two hours 1 study 8.28 0.00 8.28 15.5.23. Anti-HD (ELISA) immunoglobulin IgG-class antibodies against G Hepatitis delta virus detection with imūnfermentatīv response 1 study 15.5.24 3.46 0.00 3.46. HCV RNA load (PCR) – viral hepatitis C determination of ribonukleīnskāb by polymerase chain reaction study 15.5.25 77.07 0.00 77.07 1. HCV genotipēšan (mole of kulār hybridization) – viral hepatitis C genotypes (with subtip), 1 study 115.35
15.5.26. HCV genotipēšan 0.00 115.35 (molecular hybridization)-hepatitis C virus genotype detection without subtip) 1 study 15.5.27 68.92 0.00 68.92. HBV DNA (PCR) load-viral hepatitis B DNA quantitative detection by polymerase chain reaction study 62.83 0.00 62.83 1.15.5.28 anti-HEV IgM (ELISA) immunoglobulin M antibodies against viral hepatitis of class E with imūnfermentatīv response 1 study 4.30 0.00 4.30 anti-HEV IgG 15.5.29. (ELISA) immunoglobulin G antibodies against viral hepatitis of class E with imūnfermentatīv response 1 study 4.30 0.00 4.30 15.6. HIV/ AIDS diagnosis 15.6.1. Anti-HIV 1/2 antibody against the quick method — human immunodeficiency virus 1 and 2 with quick determination method 1 study 2.86 0.00 2.86 15.6.2. Anti-HIV 1/2, or anti-HIV 1/2 and HIV Ag (ELISA) with the certificate (ELISA) – antibody against human immunodeficiency virus 1 and 2 antibodies against at the human immunodeficiency virus 1 and 2 and the human immunodeficiency virus Antigen detection with imūnfermentatīv response 1 study 2.94 0.00 2.94 15.6.3. Anti-HIV 1/2, or anti-HIV 1/2 and/or HIV Ag with certificate and duplicate (ELISA) – antibody against human immunodeficiency virus 1 and/or 2 and HIV Antigen with imūnfermentatīv response 1 study 3.44 0.00 3.44 15.6.4. Anti-HIV 1/2 with the quick method, and a certificate – antibody against human immunodeficiency virus 1 and 2 with quick determination method 1 study 3.36 0.00 3.36 15.6.5. Anti-HIV 1/2 with the quick method, , certificates and duplicates – antibody against human immunodeficiency virus 1 and 2 with quick determination method 1 study 3.86 0.00 3.86 15.6.6. Anti-HIV 1/2 antibody (ELISA) against human immunodeficiency virus 1 and 2 determination by immune enzymatic reaction 1 study 2.44 0.00 2.44 15.6.7.

HIV load (HIV RNA Kwan)-HIV RNA quantification with PCR-1 study 83.09 0.00 83.09 15.6.8. Anti-HIV 1/2 Ag (ELISA) and HIV-antibody against at the human immunodeficiency virus 1 and 2 and the human immunodeficiency virus Antigen detection with imūnfermentatīv response 1 study 2.44 0.00 2.44 15.6.9. Anti-HIV-1 and/or 2 the confirmatory test for antibodies against the WB-human immunodeficiency virus 1 and 2 approval by Western blot reaction study 23.48 0.00 23.48 15.6.10. HIV 1 Ag (ELISA) human immunodeficiency virus Antigen with imūnfermentatīv response 1 study HIV confirmatory 10.94 0.00 10.94 15.6.11. Ag (ELISA with neutralization), human immunodeficiency virus Antigen approval with imūnfermentatīv reaction with neutralization study 31.18 0.00 31.18 15.6.12. HIV-1 (human immunodeficiency virus) genotipēšan resistance detection (sequencing) 1 study 360.60 0.00 360.60 15.7. immunological studies. Discovery-imūnstatus 15.7.1 lymphocyte imunofenotip quantitative (absolute number,%) (CD3/CD4/CD8 CD3, CD16 + CD3 CD56 CD19, HLA-DR, HLA-DR CD3/), 1 study flow citometrij 15.7.2. t-lymphocyte 20.01 0.00 20.01 imunofenotip of determination (absolute number,%) (CD3/CD 4, CD3/CD8), flow citometrij study 1. Human count 13.52 0.00 13.52 15.7.3 Antigen B tipēšan by molecular hybridization (HLA B-human leucocyt antigen of B) 1 study 81.59 0.00 81.59 15.8 Herpes group virus infection diagnostic anti-CMV IgG 15.8.1. quantitative (ELISA) immunoglobulin G antibody against citomegalovīrus class through the imūnfermentatīv reaction 1 study 3.89 0.00 3.89 anti-CMV IgM 15.8.2. (ELISA) immunoglobulin M antibodies against citomegalovīrus of class through the imūnfermentatīv reaction 1 study 3.67 0.00 3.67 15.8.3. Anti-HSV IgM ( ELISA) immunoglobulin M antibody-class against herpes simplex virus type 1 and 2 with imūnfermentatīv response 1 study HSV1/2 Ag 3.67 0.00 3.67 15.8.4. IFA – herpes simplex virus 1 and 2 types of Antigen detection by microscopy study of imūnfluorescenc 1 5.17 0.00 5.17 15.8.5. Anti-IgG quantitative HSV1/2 (ELISA) immunoglobulin G class antibodies against herpes simplex type 1 and 2 a quantification with imūnfermentatīv response 1 study 3.89 0.00 3.89 15.8.6. Anti-HSV-2 IgG (ELISA) immunoglobulin G antibody class against herpes simplex type 2 with imūnfermentatīv response 1 study 3.67 0.00 3.67 15.8.7. Anti-HSV-2 IgM (ELISA) immunoglobulin M antibody class against herpes simplex type 2 with imūnfermentatīv response 1 study 4.67 0.00 4.67 15.8.8. Anti-VZV (HZV) IgM (ELISA) immunoglobulin M antibodies against Varicell of the class (or herpes zoster) zoster virus detection with imūnfermentatīv response 1 study 3.67 0.00 3.67 15.8.9. Anti-VZV (HZV) IgG quantitative (ELISA) immunoglobulin G antibody-class against the Varicell (or herpes zoster) zoster virus quantification the reaction of imūnfermentatīv with 1 study 3.89 0.00 3.89 15.8.10. CMV anti-IgG aviditāt (ELISA) immunoglobulin G antibodies against citomegalovīrus of class aviditāt with imūnfermentatīv determination of reaction 1 study DNA quantitative CMV 5.84 0.00 5.84 15.8.11. (PCR-RL) – citomegolovīrus's (CMV DNA) DNA quantification with PCR in real time (RT-PCR) 1 study DNA 15.8.12 qualitative 34.58 0.00 34.58. CMV (PCR) – citomegalovīrus's DNA (CMV DNA) identification with polymerase chain reaction (PCR) 1 study 8.51 0.00 8.51.15.8.13 anti-EBV EA IgM (ELISA) immunoglobulin The m-class antibodies against Epstein-Barr virus early Antigen detection with imūnfermentatīv response 1 study 3.58 0.00 3.58.15.8.14 anti-EBV EA IgG quantitative (ELISA) immunoglobulin G antibody against Epstein in class-Barr virus early Antigen (EA) determination by the imūnfermentatīv reaction 1 study 3.58 0.00 3.58 15.8.15. Anti-EBV VCA IgM (ELISA) immunoglobulin M antibody against Epstein in class-Barr viral antigen detection by a skin reaction 1 imūnfermentatīv study 15.8.16 3.58 0.00 3.58. Anti-EBV VCA IgG quantitative (ELISA) immunoglobulin G antibody against Epstein in class-Barra viral skin quantitative determination of Antigen with imūnfermentatīv response 1 study 3.58 0.00 3.58 15.8.17. Anti-EBV IgG quantitative EBN (ELISA) immunoglobulin G antibody against Epstein in class-Barr virus nuclear antigen determination with imūnfermentatīv response 1 study 3.58 0.00 3.58.15.8.18 anti-EBV IgM, WB-immunoglobulin M antibody against Epstein in class-Barra viral validation by Western blot reaction 1 study 23.65 0.00 23.65.15.8.19 anti-EBV IgG immunoglobulin G, WB-class antibodies against Epstein-Barr virus confirmation with Western blot reaction 1 study 23.65 0.00 23.65 EBV 15.8.20. Quantitative DNA (PCR-RL), Epstein-Barr virus (EBV) DNA (DNA) identification by PCR in real time (RT-PCR) 1 study 15.8.21 EBV DNA 34.58 0.00 34.58. qualitative (PCR), Epstein-Barr virus (EBV) DNA (DNA) detection quality with polymerase chain reaction (PCR-RT) 1 study 15.8.22 8.51 0.00 8.51. HSV 1/2 DNA quantitative (PCR-RL)-Herpes simplex type 1 and 2 a quantitative determination of DNA by polymerase chain reaction real time study 1st HSV1/2 34.58 0.00 34.58.15.8.23 DNA (PCR) quality – herpes simplex 1. and the dezoksiribonukleīn acid subtip 2 (DNS) quality by polymerase chain reaction (PCR) 1 study 8.51 0.00 8.51.15.8.24 herpes virus isolation and tipēšan (tissue culture) study 15.8.25 11.86 0.00 11.86.1 M class immunoglobulin antibodies against group a infection T.O.R.C.H. (toxoplasmosis, rubella, herpes infections and citomegalovīrus) by Western blot reaction 1 study 23.65 0.00 23.65 15.8.26. VZV (HZV) DNA quantitative (PCR-RL) – Varicell's (or herpes zoster) zoster virus DNA quantitative detection by polymerase chain reaction (PCR) real time study 1st 34.58
(HZV) 15.8.27 0.00 34.58. VZV DNA (PCR) – quality of Varicell (or herpes zoster) zoster virus DNA detection by polymerase chain reaction (PCR) 1 study 8.51 0.00 8.51 15.9. respiratory viral infection Diagnostics 15.9.1. virus influenza A Antigen with imūnfluorescenc microscopy study of 1 influenza B virus 4.92 0.00 4.92 15.9.2. Antigen detection by microscopy of imūnfluorescenc 1 the examination and/or 4.92 0.00 4.92 15.9.3. (A) (B) influenza viruses (RNA) ribonukleīnskāb quality with the polymerase chain reaction (PCR-RL) real time 1 study
15.9.4.20.00 0.00 20.00 A flu virus of subtip determination by polymerase chain reaction in real time (RT-PCR), if A flu virus RNA (RNA) is positive 1 study 15.11 0.00 15.11 15.9.5. paragrip virus Antigen by microscopy study of imūnfluorescenc 1 paragrip 4.92 0.00 4.92 15.9.6. virus tipēšan with imūnfluorescenc-microscopy study of 1 adenovīrus Antigen 6.90 0.00 6.90 15.9.7. determination by microscopy study of imūnfluorescenc 1. adenovīrus distribution of 4.92 0.00 4.92 15.9.8 from clinical material (tissue culture) study 1 8.04 0.00 8.04 15.9.9.
complement fixation antibody for detection against adenovīrus 1 the examination in sincitiāl 4.83 0.00 4.83 15.9.10. respirators virus Antigen (RSV, Ag) determination by microscopy study of imūnfluorescenc 1 15.9.11 4.92 0.00 4.92. Anti-RSV IgM (ELISA) immunoglobulin M antibodies against respiratory class in virus detection with sincitiāl imūnfermentatīv response 1 study 3.61 0.00 3.61 15.9.12. haemagglutination inhibition reaction (HAKR) antibodies against the A/H3N2, (B), A/H1H1 flu viruses detection 1 study 3.29 0.00 3.29 15.9.13. haemagglutination inhibition reaction (HAKR) antibody against paragrip I , (II), (iii) the determination of the type 1 study 3.29 0.00 3.29 15.9.14. Anti-Influenza A/IGA (ELISA) immunoglobulin class of antibodies against influenza viruses A through study of the imūnfermentatīv reaction 1 3.68 0.00 3.68 15.9.15. Anti-Influenza A/IgG (ELISA) immunoglobulin G antibody-class against influenza viruses A through study of the reaction of 1 imūnfermentatīv 3.46 0.00 3.46 15.9.16. Anti-influenza B/IGA (ELISA) immunoglobulin class of antibodies against influenza B viruses detection with imūnfermentatīv response 1 study 3.68 0.00 3.68.15.9.17 anti-B/influenza IgG (ELISA)- Immunoglobulin G antibody against class B flu viruses detection with imūnfermentatīv response 1 study 3.46 0.00 3.46 15.9.18. influenza virus isolation in tissue culture and 15.9.19 tipēšan 1 the examination 12.01 0.00 12.01. influenza virus resistance determination by sequencing method 1 study 15.9.20 111.70 0.00 111.70. influenza virus isolate sensitivity to the preparations through study of the imūnfermentatīv reaction of 1.15.9.21 preparation virucidāl 18.47 0.00 18.47 activity determination by titration in tissue culture

1 study of human 15.9.22. meta 15.01 0.00 15.01 pneumo (hMPV) determination by microscopy of imūnfluorescenc 1 study. acute 4.94 0.00 4.94 15.10 viral gastroenteritis diagnostic 15.10.1. adenovīrus Ag (ELISA)-adenovīrus with imūnfermentatīv the Antigen response 1 study 3.67 0.00 3.67 15.10.2. rotavirus Ag (ELISA)-rotavirus Antigen with imūnfermentatīv response 1 3.67 0.00 3.67 15.10.3. astrovīrus study of Ag (ELISA)-astrovīrus with imūnfermentatīv the Antigen response 1 the study programme identifying norovirus 3.67 0.00 3.67 15.10.4. Ag (ELISA) – programme identifying norovirus Antigen detection by imūnfermentatīv reaction
1 study of ribonukleīnskāb of 6.03 0.00 6.03 15.10.5. programme identifying norovirus (RNA) of high quality with the polymerase chain reaction (PCR) 1 study involved infections 8.51 0.00 8.51 15.11. Diagnostics 15.11.1. withdrawal and involved tipēšan (tissue culture), 1 study 13.73 0.00 13.73 15.11.2. involved in the determination of antibodies against complement fixation 1 of 5.06 0.00 5.06 15.11.3. study involved quantitative RNA (PCR-RL) – ribonukleīnskāb's involved a determination by the polymerase chain reaction real time 1 the study of RNA involved 34.58 0.00 34.58 15.11.4. qualitative (PCR)-the identification of the involved ribonukleīnskāb with polymerase chain reaction 1 study involved the distribution of 8.51 0.00 8.51 15.11.5. tissue culture study 8.04 0.00 8.04 15.11.6 1. neutralization reaction tissue culture for detection of antibodies against poliovīrus 1 the examination 6.55 0.00 6.55 15.11.7. Anti-a antibodies involved with imūnfermentatīv response 1 study 10.58 0.00 10.58 15.12. tick-borne infection Diagnostics 15.12.1. Anti-TBE IgM likvor (ELISA) immunoglobulin M antibodies against ticks class encephalitis virus detection with imūnfermentatīv response 1 study 4.60 0.00 4.60 15.12.2. Borrelia burgdorferi anti-IgG immunoglobulin G (WB)-class antibody against Borrelia burgdorferi approval by Western blot reaction 1 study 18.52 0.00 18.52 15.12.3. Borrelia burgdorferi anti-IgM (WB) – immunoglobulin M antibody class against Borrelia burgdorferi approval by Western blot reaction 1 study 18.52 0.00 18.52 15.12.4. Borrelia burgdorferi anti-IgM (ELISA) immunoglobulin M antibody class against Borrelia burgdorferi determination by imūnfermentatīv response 1 study 3.44 0.00 3.44 15.12.5. Anti-TBE IgM (ELISA) immunoglobulin M antibodies against ticks class encephalitis virus detection with imūnfermentatīv response 1 study 4.60 0.00 4.60 15.12.6. Anti-TBE IgG ( ELISA) immunoglobulin G antibody-class against tick encephalitis virus detection with imūnfermentatīv response 1 study 4.71 0.00 4.71 15.12.7. Anti-Ehrlichi (Anaplasm) with imūnfluorescenc in study 1 IgG 12.58 0.00 12.58 15.12.8. Anti-Ehrlichi (Anaplasm) imūnfluorescenc 1 the examination with IgM 12.58 0.00 12.58 15.12.9. Borrelia burgdorferi anti-IgG (quantitative) (ELISA) immunoglobulin G class antibodies against Borrelia burgdorferi determination by imūnfermentatīv response 1 study 3.44 0.00 3.44 15.12.10. Borrelia DNA (PCR-RL)-DNA detection of Borrelia through polymerase chain reaction real time study 1st 28.95 0.00 28.95
15.13. rare and imported infections the serological and molecular biological diagnosis 15.13.1. Anti-virus IgM Hunt (ELISA) immunoglobulin M antibodies against the hunt class virus detection with imūnfermentatīv response 1 study 11.35 0.00 11.35. Hunt 15.13.2 anti-IgG (ELISA) immunoglobulin G antibody against the hunt class virus detection with imūnfermentatīv response 1 study 11.35 0.00 11.35 15.13.3. Anti-IgM burett of Coxiell (Q fever, ELISA) immunoglobulin M antibodies against Coxiell of the class of antigens by burnett imūnfermentatīv response 1 study 12.41 0.00 12.41 15.13.4. Anti-IgG (Coxiell of Q burnett fever, ELISA) immunoglobulin G antibody against the class Coxiell Antigen detection by burnett imūnfermentatīv reaction study 15.13.5 11.75 0.00 11.75 1. Anti-pneumophil of the IgM Legionell (ELISA) immunoglobulin M antibodies against class a pneumophil discovery with Legionell imūnfermentatīv response 1 study 4.93 0.00 4.93 15.13.6. Anti-pneumophil of IgG Legionell (ELISA) immunoglobulin G antibody against the class of the pneumophil discovery with Legionell imūnfermentatīv response 1 the study of the pneumophil of 15.13.7.4.93 0.00 4.93 Legionell Ag detection in urine 1 study 9.43 0.00 9.43.15.13.8 anti-Deng-IgM (ELISA) – immunoglobulin M antibody class against Deng viral detection with imūnfermentatīv response 1 study 5.86 0.00 5.86.15.13.9 anti-Deng-IgG (ELISA) immunoglobulin G antibody against a class of virus detection by Deng imūnfermentatīv response 1 the study of RNA 5.86 0.00 5.86. Deng 15.13.10 (PCR-RL)-Deng-ribonukleīnskāb detection of virus by PCR in real time study 1st 39.90 0.00 39.90 15.13.11. Anti-Puumal-IgM (ELISA) immunoglobulin M antibody-class against the Puumal virus detection with imūnfermentatīv response 1 study 11.39 0.00 11.39.15.13.12 anti-West-Nile (ELISA) immunoglobulin IgM-class antibodies against M West-Nile virus detection with imūnfermentatīv response 1 study 5.86 0.00 5.86.15.13.13 anti-West-Nile (ELISA) immunoglobulin IgG-class antibodies against a G West-Nile virus detection with imūnfermentatīv response 1 study 15.13.14. West-5.86 0.00 5.86 Nile RNA (PCR RL) West-Nile virus detection ribonukleīnskāb by polymerase chain reaction real time study 15.13.15 39.84 0.00 39.84 1. Sars CoV (PCR RL) – SARS CoV ribonukleīnskāb detection with polymerase chain reaction real time study 15.13.16 39.84 0.00 39.84 1. Bacillus DNA with anthrac by polymerase chain reaction
1 study 20.51 0.00 20.51 15.13.17. Mycobacterium leprae DNA detection by polymerase chain reaction 1 study 20.51 0.00 20.51.15.13.18 anti-Chlamydia IgM immunoglobulin M psitac-class antibody to Chlamydia psitac in detection with imūnfluorescenc method 1 study 11.30 0.00 11.30.15.13.19 anti-Chlamydia-IgG immunoglobulin G psitac class psitac of the antibody against Chlamydia detection with imūnfluorescenc method 1 study 8.95 0.00 8.95 15.13.20. Anti-IgM immunoglobulin M of Rickettsi-class antibodies against Rickettsi (Spotted Fever and the Fever team Typh) detection with imūnfluorescenc method 1 study
15.13.21 Rickettsi 6.30 0.00 6.30. Anti-IgG-class antibodies of immunoglobulin G against Rickettsi (Spotted Fever and the Fever team Typh) determination by the method of study imūnfluorescenc 1.15.13.22 anti-6.30 0.00 6.30 Rab to IgG (ELISA) immunoglobulin G antibody-class against the Rab to virus with imūnfermentatīv response 1 the study of immunoglobulin M 13.05 0.00 13.05.15.13.23 antibody against Chikungunij class virus detection with imūnfluorescenc method 1 the study of immunoglobulin G 23.85 0.00 23.85.15.13.24 antibody against Chikungunij class virus detection with imūnfluorescenc method 1 study 23.85 0.00
23.85 15.13.25. immunoglobulin M antibodies against class Sandifly fever virus detection with imūnfluorescenc method 1 the study of immunoglobulin G 23.85 0.00 23.85.15.13.26 antibody against class Sandifly fever virus detection with imūnfluorescenc method 1 the study of immunoglobulin G 23.85 0.00 23.85 15.13.27. class of antibodies against the virus in South East Asia, Chikungunij virus, Japanese encephalit a virus detection with imūnfluorescenc method 1 the study of immunoglobulin M 23.85 0.00 23.85 15.13.28. class antibodies against dengue virus detection with imūnfluorescenc method 1 the study of immunoglobulin 23.85 0.00 23.85 15.13.29. (G) class of antibodies against dengue virus detection with imūnfluorescenc method 1 the study of immunoglobulin M 23.85 0.00 23.85 15.13.30. class of antibodies against SARS for determination by imūnfluorescenc Coronavir method 1 the study of immunoglobulin G 23.85 0.00 23.85 15.13.31. class of antibodies against SARS for determination by imūnfluorescenc Coronavir method 1 the study of immunoglobulin M 23.85 0.00 23.85 15.13.32. class of antibodies against Flavivir (TB, West Nile, Japanese by encephalit , Yellow fever virus) by imūnfluorescenc method 1 the study of immunoglobulin G 23.85 0.00 23.85 15.13.33. class of antibodies against Flavivir (TB, West Nile, Yellow fever, Japanese encephalit viruses) detection with imūnfluorescenc method 1 the study of immunoglobulin M 23.85 0.00 23.85 15.13.34. class of antibodies to Crimean-Congo Fever virus detection with imūnfluorescenc method 1 the study of immunoglobulin G 46.85 0.00 46.85.15.13.35 antibody against class Crimean-Congo Fever virus detection with imūnfluorescenc method 1 study different 15.14 46.85 0.00 46.85 infectious disease serological and molecular biological Diagnostics 15.14.1. Anti-rubella IgM (ELISA) immunoglobulin M antibodies against rubella class virus detection with imūnfermentatīv response 1 study 3.76 0.00 3.76 15.14.2. Anti-rubella quantitative IgG (ELISA) immunoglobulin G antibodies against rubella class viral quantification with imūnfermentatīv response 1 study 3.98 0.00 3.98

15.14.3. Anti-Mycoplasma pneumoniae IgM (ELISA) immunoglobulin M antibodies against Mycoplasma class pneumoniae with imūnfermentatīv response 1 study 4.37 0.00 4.37 15.14.4. Anti-Mycoplasma pneumoniae IgG (ELISA) immunoglobulin G antibody against Mycoplasma class pneumoniae with imūnfermentatīv response 1 study 4.57 0.00 4.57.15.14.5 anti-Chlamydia pneumoniae IgM (ELISA) immunoglobulin M antibodies against Chlamydia class pneumoniae with imūnfermentatīv response 1 study 4.87 0.00 4.87.15.14.6 anti-Chlamydia pneumoniae IgG quantitative (ELISA) immunoglobulin G antibody against Chlamydia class pneumoniae determination by imūnfermentatīv reaction
1 study 4.87 0.00 4.87 15.14.7. Anti-Toxoplazm-IgM (ELISA) immunoglobulin M antibody-class against the determination of Toxoplazm with the imūnfermentatīv reaction 1 study 3.33 0.00 3.33 15.14.8. Anti-Toxoplazm IgG (quantitative) (ELISA) immunoglobulin G antibodies against Toxoplazm of class identification with imūnfermentatīv response 1 study 3.09 0.00 3.09 15.14.9. Anti-Toxoplazm IGA (ELISA) immunoglobulin A antibodies against Toxoplazm of class determination with imūnfermentatīv manmad reaction 1 study 3.51 0.00 3.51.15.14.10 anti-Toxoplazm IgG aviditāt (ELISA) immunoglobulin G antibody against Toxoplazm classes in the aviditāt detection with manmad imūnfermentatīv study of the reaction of 1 15.14.11 4.02 0.00 4.02. Anti-Rubeol-IgM (ELISA) immunoglobulin M antibody-class against the measles virus detection with imūnfermentatīv response 1 study 3.76 0.00 3.76.15.14.12 anti-Rubeol IgG quantitative (ELISA) immunoglobulin G antibody against measles class viral quantification with imūnfermentatīv response 1 study 3.98 0.00 3.98 15.14.13. (Rubeol) measles virus isolation in tissue culture study 8.04 0.00 8.04 15.14.14 1. parvovīrus B19 IgM anti-a (ELISA) immunoglobulin M antibodies against parvovīrus of the class with imūnfermentatīv B19 reaction 1 study 3.67
0.00 3.67 15.14.15. Anti-parvovīrus-B19 IgG quantitative (ELISA) immunoglobulin G antibodies against parvovīrus of class determination with B19 imūnfermentatīv response 1 study 3.89 0.00 3.89 15.14.16. Anti-Diphteri-Toxoin (ELISA) immunoglobulin IgG-class antibodies against the G Diphteri's Toxoin by imūnfermentatīv response 1 study 4.22 0.00 4.22.15.14.17 anti-IgM Mump (ELISA) immunoglobulin M antibodies against mumps class virus detection with imūnfermentatīv response 1 study 5.28 0.00 5.28 15.14.18. Anti-IgG by Mump (ELISA) immunoglobulin G antibody-class against mumps virus detection to the imūnfermentatīv response 1 the study 15.14.19 4.77 0.00 4.77. papilloma virus (PCR) (low and high risk of oncogenes) identification with molecular biological methods study 18.10 0.00 18.10 15.15 1. bacteriological studies 15.15.1. bacteriological analysis 15.15.1.1. blood plating automatic system 1 study 15.15.1.2. lumbālpunktāt plating 10.64 0.00 10.64 1 study the culture of the 15.15.1.3.8.23 0.00 8.23 neck isseri meningitidis of detection Not 1 study 8.02 0.00 8.02. urine culture 1 15.15.1.4 study 15.15.1.5. bile passage 6.94 0.00 6.94 1 of 5.06 0.00 5.06 study 15.15.1.6 pus. , discharge, punktāt, rinsing water plating study 7.16 0.00 7.16 15.15.1.7.1 sputum inoculum 1 study 15.15.1.8 plating of 6.94 0.00 6.94. neck, nose-beta haemolytic streptococci 1 study on culture 15.15.1.9 6.56 0.00 6.56. different materials – Staphylococcus aureus 1 study. 15.15.1.10 plating from 5.36 0.00 5.36 neck and nose-Corynebacterium diphtheriae 1 study 4.85 0.00 4.85 Corynebacterium diphtheriae 15.15.1.11. toksigēn strains of DNA detection by polymerase chain reaction study 8.51 0.00 8.51 15.15.1.12 1. faecal culture of Shigella The determination of the salmonella study 5.93 0.00 5.93 15.15.1.13 1. faeces-Pathogenic Escherichia coli 1 study 5.73 0.00 5.73 15.15.1.14. different materials-1 study of Enterobacteriaceae 3.31 0.00 3.31 15.15.1.15. materials (faeces, urine from the neck)-Yersinia genus bacteria, with the conventional method study 5.43 0.00 5.43 15.15.1.16 1. plating of different materials of the genus Candida fungus determination study 5.71 0.00 5.71 1 15.15.1.17. materials (faeces, urine the lumbar punktāt,, blood)-the genus Campylobacter bacteria study 1.15.15.1.18 plating 4.71 0.00 4.71 anaerobic microflora discovery 1 study-15.15.1.19. faeces 7.01 0.00 7.01 Vibrio cholerae study 5.44 0.00 5.44 15.15.1.20.1 the antibiotic sensitivity detection of micro-organisms with the unified system study 1. botulism-bioprov 15.15.1.21 6.42 0.00 6.42 1 study the 13.53 0.00 13.53.15.15.1.22 micro-organisms antibiotic sensitivity determination by disk method 1 the study of the culture 15.15.1.23.4.36 0.00 4.36 different materials – MRSA Methicillin S. aureus 7.80 0.00 7.80 study 15.15.1.24 1.
in s. aureus Methicillin Mec Gene Discovery (MRSA) by polymerase chain reaction in real time (RT-PCR) 1.15.15.1.25 mikobaktērij-34.58 0.00 34.58 study bakterioskopisk investigated by fluorescent method 1 study material plating 2.15 0.00 2.15 15.15.1.26. genus Mycobacterium detection of microorganisms 1.15.15.1.27 plating 4.03 0.00 4.03 study TB diagnosis with the BACTEC system 1 study Sharia 17.70 0.00 17.70 15.15.1.28. Mycobacterium complex DNA Discovery (m. Sharia , M. Bovis, m., m. "african microt) by polymerase chain reaction (PCR-RL) real time 1 study Sharia 15.15.1.29 28.82 0.00 28.82. Mycobacterium complex DNA and resistance against the simultaneous determination of rifampicīn by polymerase chain reaction (PCR-RL) real time 1 the study of microscopic 50.38 0.00 50.38 15.15.1.30. leprosy diagnostic 1 study 15.15.1.31 2.60 0.00 2.60. Mycobacterium leprae DNA detection by polymerase chain reaction (PCR) 1 study 15.15.2. serological analysis 34.58 0.00 34.58 15.15.2.1. agglutination reaction of bacterial infection (for example , whooping cough, typhoid fever, tularemia, brucellosis) 1 study 2.01 0.00 2.01 15.15.2.2. Aspergillus Antigen with lateksaglutinācij (LA) 1 study 4.35 0.00 4.35 15.15.2.3. Candida Antigen with lateksaglutinācij (LA) (1) the study of the reaction of HA 15.15.2.4 4.09 0.00 4.09. bacterial infection (salmonellosis, shigellosis, yersiniosis, pseidotuberkuloz) 1. Cryptococc of 15.15.2.5 study 2.51 0.00 2.51 Antigen with lateksaglutinācij (LA) 1 study 4.42 0.00 4.42 Clostridium difficile 15.15.2.6. (A) the determination of toxins 1 study 5.15 0.00 5.15 15.15.2.7. Group A beta haemolytic Streptococcus in the quick test
1 study 2.30 0.00 2.30 15.15.3. bacteriological studies of the genus Mycobacterium TPSK. 15.15.3.1 micro-determination of sensitivity to medications in row 1 with BACTEC (foreign nationals) 1 procedure 15.15.3.2 85.29 0.00 85.29. sensitivity of the micro-organisms of the genus Mycobacterium detection to row 2 medicines with the BACTEC (foreign nationals) 1 procedure 113.43 0.00 113.43 15.15.3.3. diferenciāltest micro-organisms Mycobacterium genus (NAP) with the BACTEC (foreign nationals) 1 procedure 15.15.3.4 57.20 0.00 57.20. sensitivity of micro-organisms of the genus Mycobacterium detection against pirazinamīd with a BALTEC (foreign nationals) 1 procedure 35.17 0.00 35.17 15.15.3.5.
The sensitivity of micro-organisms of the genus Mycobacterium detection against 1. medications to the hard line feeds (foreign nationals) 1 procedure 15.15.3.6 9.77 0.00 9.77. sensitivity of the micro-organisms of the genus Mycobacterium detection to row 2 medications on hard medium (foreign nationals) 1 procedure 15.15.3.7 10.87 0.00 10.87. Lipo test (diferenciāltest micro-organisms of the genus Mycobacterium, determination of the sensitivity to isoniazīd and rifampicīn) (foreign nationals) 1 procedure 40.50 0.00 40.50 No 15.16. environmental studies 15.16.1. objects HAVE Ag (ELISA) – viral hepatitis A Antigen with imūnfermentatīv reaction (sanitary examination) 1 study 8.96 0.00
15.16.2.8.96 Bacillus anthrac DNA detection by polymerase chain reaction real time 1 study involved adenovīrus 39.84 0.00 39.84 15.16.3. and distribution of tissue culture (sanitary examination) (1) study the tick encephalitis 15.16.4.33.09 0.00 33.09 (TBE) virus Antigen (ELISA) imūnfermentatīv reaction to mite 1 study 15.16.5. tick encephalitis 10.97 0.00 10.97 (TBE) virus DNA tick with the polymerase chain reaction (PCR-RL) real time study 1st 19.58 0.00 19.58 15.16.6. Borrelia DNA (PCR-RL) tick-tick of the Borrelia DNA with molecular hybridisation 1 study
15.16.7. the washings from 13.58 0.00 13.58 ambient objects-1 study of the culture 15.16.8. surgical 6.34 0.00 6.34 material, instrument for the determination of the investigation, the level 1 study laboratory studies 3.47 0.00 3.47 15.17. other medical institutions study the League 1-price 0.00 League-15.18. morphological study of price-liver bioptāt light microscopy study 13.16 1

16. Image diagnostika1 0.00 13.16 16.1 16.1.1. ultrasonoskopisk the abdominal sonogrāfij (not including the pelvic organs, with vascular measurement) study 1. one organ 10.35 0.00 10.35 16.1.2 repeated sonogrāfij (one study), 1 study, 16.1.3. kidney 5.90 0.00 5.90 urinary tract, prostate sonogrāfij study 1 9.83 0.00 9.83 16.1.4. a woman's pelvic organs examination 1 sonogrāfij 9.83 0.00 9.83 16.1.5. mammary sonogrāfij 1 the examination 9.83 0.00 9.83 16.1.6. ultrasonic controls made puncture 1 study 24.18 0.00 24.18 16.1.7. thyroid , muscle, tendons, joints and other superficial structures ultrasound placed 1 9.32 0.00 9.32 16.1.8. rectal examination and intravagināl in sonogrāfij 1 the examination in radiological investigation 8.28 0.00 8.28 16.2 16.2.1. thoracic cavity organs 1 study screened 5.28 0.00 5.28 16.2.2. thoracic cavity organs review company 1 study 5.21 0.00 5.21 16.2.3. thoracic cavity organs company in two planes 1 study 8.32 0.00 8.32 16.2.4. thoracic cavity organs one additional company , including esophageal kontrastēšan 1 the examination 6.47 0.00 6.47 16.2.5. other institutions assessment of the x-ray images one study 1 study 2.07 0.00 2.07 16.2.6. abdominal examination 1 screened 4.71 0.00 4.71 16.2.7. abdominal company 1 study 4.90 0.00 4.90 16.2.8. esophageal kontrastizmeklēšan (and Gramma screened) study 1 14.18 0.00 14.18 16.2.9. esophageal, gastric and duodenal kontrastizmeklēšan 1 the examination of 22.44 0.00 22.44 16.2.10. esophageal , the stomach and the duodenum to the rectum, small intestine kontrastizmeklēšan the investigation to study the ileocekāl area 1 24.89 0.00 24.89 16.2.11. colon Arcade 1 20.37 0.00 20.37 16.2.12. irigoskopij study 1 study 37.90 0.00 37.90 16.2.13. urogrāfij intravenous study 1. skull 21.97 0.00 21.97 16.2.14 part 1 of each radiograph examination 4.66 0.00 4.66 16.2.15. skull x-ray images two planes 1 study 7.28 0.00 7.28 16.2.16. mandibular x-ray images (biplane) 1 study 16.2.17 5.90 0.00 5.90. sinus x-ray images of one study 1 4.18 0.00 4.18
16.2.18. one dental company 1 study 1.85 0.00 1.85 16.2.19. the chest bone or part of a single radiograph 1 study 6.21 0.00 6.21 16.2.20. extremity or part of a single radiograph 1 study 8.35 0.00 8.35.16.2.21 the shoulder bar or a pelvic x-ray images of part 1 of the study 16.2.22 4.99 0.00 4.99. pelvic bone radiograph 1 statement of study 16.2.23. part of the spine 6.47 0.00 6.47 one radiograph (biplane) (1) the study of digital x-ray 8.39 0.00 8.39.16.2.24 image recording on disc 1 study 1.55 0.00 1.55
16.2.25. liver puncture Biopsy study 35.01 0.00 35.01 16.2.26 1. larynx, throat, trachea, oesophagus, one of the top 1 study 16.2.27. digital print 5.54 0.00 5.54 on 24 x 30 cm movie 1 study 16.2.28. digital print 2.07 0.00 2.07 to 35 x 43 cm films 1 study 2.07 0.00 2.07 16.2.29 head and sinus CT without an examination of the kontrastēšan 1 16.2.30 60.00 0.00 60.00. abdominal CT without kontrastēšan 1 of multi-layer study 16.2.31. small pelvis 70.00 0.00 70.00 multi-layer CT free kontrastēšan 1 study 16.2.32. pulmonary 70.00 0.00 70.00 radiological study with mobile x-ray equipment 1 study 11.08 0.00 11.08 16.2.33. chest CT without kontrastēšan multi-layer 1 study. 16.2.34 spine CT 65.00 0.00 65.00 without kontrastēšan 1 the examination 17. Functional 70.00 0.00 70.00 17.1. gastroskopij diagnostika1 and/or partial sample of duodenoskopij without ekscīzij and/or puncture 1 study 17.58 0.00 17.58 17.2. gastroskopij and/or partial sample of duodenoskopij with ekscīzij and/or puncture and urease reporting 1 study 24.08
0.00 24.08 17.3. ezofagoskopij free sample of ekscīzij and/or puncture 1 study 7.29 0.00 7.29 17.4. ezofagoskopij with ekscīzij of the sample and/or puncture 1 study 13.86 0.00 13.86 17.5. rektoskopij 1 the examination complete 4.51 0.00 4.51 10.9. colon examination 1 study probing 50.00 0.00 50.00 17.7 duodenāl 1 the examination 5.67 0.00 5.67 11.1. cleaning enema 1 study 4.45 0.00 4.45 11.1. never perform manipulation due to unforeseen circumstances 1 study 27.33 0.00 27.33 17.10. patient sedation during endoscopic examination
1 study with flexible 4.12 0.00 4.12 17.11. sigmoidoskopij instruments, including rektoskopij 1 study 16.71 0.00 16.71 17.12. colon examination with flexible instruments, including the rektoskopij to the lean angle 1 study 23.91 0.00 23.91 17.13. colon examination with flexible an endoscope, including rektoskopij and sigmoidoskopij, the ekscīzij and/or puncture 1 study 38.95 0.00 38.95 17.14. to mucous membranes due to the sampling of polip cut and/or biopsy of the node using high-frequency power tools 1 study 24.18 0.00 24.18 17.15. more than two sampling of mucous membranes due to the cut and/or polip node biopsy, using high-frequency power tools, premium at 17.2, 17.4, 17.5, 17.11 17.12.17.13 and.., referred to in subparagraph 1 manipulation study 28.90 0.00 28.90 17.16. fat gut clean-up method for the preparation of the patient thick intestinal endoscopic examination or irigoskopij with enema 1 study 3.66 0.00 3.66 17.17. the pulse frequency and arterial pressure 1 study with 17.18.0.31 0.00 0.31 electrocardiography leads (12 the notation) 1 study with 12 1.19 0.00 1.19 17.19. electrocardiography leads (description) 1 study 2.30 0.00 2.30 17.20. electrocardiography with less than 12 leads (note) 1 study 0.74 0.00 0.74 17.21. electrocardiography with less than 12 leads (description) 1 1.01 0.00 1.01 17.22. during the study description (compared to at least five the ECG) 1 study 3.28 0.00 3.28 17.23. electrocardiography (recorded with a portable machine on site) 1 study of 3.48 0.00 3.48 17.24. ehokardiogrāfij mode M and B real time unit and haemodynamic indicators determination of dopplerogrāfij and spectral 1 study 21.55 0.00 21.55 17.25. external respiration KPI (VC, and Tiffn with the index) discovery and analysis of study diffusion 2.47 0.00 2.47 17.26.1 1 procedure 10.20 0.00 10.20 1 17.27. veloergometrij procedure spirogāfij procedure 1 8.41 0.00 8.41 17.28.4.50 0.00 4.50 spirogrāfij with the bronhodilatācij of 17.29. test and pretbaktērij filter procedure 1 load kardiopulmonāl 6.00 0.00 6.00 17.30. assay procedure 1 11.11 0.00 11.11 18. Bronhoskopija1. bronhoskopij with the rigīd 18.1 bronhoskop 1 procedure 12.10 0.00
fibrobronhoskopij 12.10 18.2 1 procedure transbronhiāl 18.3. lymph nodes 18.40 0.00 18.40 biopsy of the ultrasonoskopij control endobronhiāl (EB) procedure 1 150.00 0.00 150.00 18.4. bonus on trachea and bronchial mucosa biopsy procedure 1 7.10 0.00 7.10 18.5. supplement for transbronhiāl lung tissue biopsy procedure 1 8.12 0.00 8.12 18.6. bonus on videoskopij equipment 1 procedure 6.00 0.00 6.00 11.6. bonus on bronchial alveolar-lavāž (BALA) 1 procedure 3.43 0.00 3.43. foreign body removal from 12.8 respiratory 1 procedure 5.01 0.00 5.01 11.7.
latent tuberculosis infection detection test in vitro procedure 19.51.00 0.00 51.00 1 other manipulation and procedūras1 19.1 19.2 the Mantoux procedure 1 0.80 0.00 0.80 Mantoux reaction procedure 1 read 0.40 0.00 0.40 19.3. skin prick test with 1 allergen 1 procedure 2.21 0.00 2.21 19.4. skin prick test for each allergen 1 procedure Dermotoloģisk 0.80 0.00 0.80 investigation and 20. ārstēšana1.1 dermatoskopij procedure 20.1 4.80 0.00 4.80 20.2. dermatoskopij (for each subsequent formations) 1 procedure 2.40 0.00
2.40 20.3. cryotherapy (one build to destruction) 1 procedure 3.60 0.00 3.60 20.4. elektrokoagulācij (one build to destruction) 1 procedure dermatoloģiskie by 3.60 0.00 3.60 20.5. bandage patients 1 procedure shall be 1.20 0.00 1.20 20.6. bandage dermatoloģiskie patients (with drugs) 1 procedure 2.40 0.00 2.40 20.7. Bioptron lamp treatment (5 min) 1 procedure kriomasāž procedure 1 2.40 0.00 2.40 12.9.-20.9. male urethra 6.00 0.00 6.00 flushing and drug instilācij 1 procedure 3.60 0.00 3.60 20.10. vaginal or cervical or drug treatment drug provocation STS 1 procedure for determining 3.60 0.00 3.60 20.11. skin biopsy procedure 1 perform 20.12.18.00 0.00 18.00 skin sample histological investigation procedure 14.40 0.00 14.40 20.13 1. Prostate Massage, getting a prostate izspiedšķidrum 1 procedure no bleeding parafimoz 8.40 0.00 8.40 20.14. liquidation (without anesthesia) 1 procedure 7.20 0.00 7.20 20.15. both feet nail and skin treatment procedure 1 15.00 0.00 15.00 both feet-20.16. processing procedure 1 8.00 0.00 8.00 20.17. both feet skin treatment procedure 8.00 1
0.00 8.00 20.18.

one of the processing procedure 1 callosity appearance 1.80 0.00 1.80 20.19. one foot nail treatment 1 procedure 3.00 0.00 3.00 20.20. medication application procedure 1.80 0.00 1.80 1 notes.
1 value added tax does not apply, in accordance with the law "on value added tax" article 6, first paragraph, point 9.1.
2 value added tax does not apply, in accordance with the law "on value added tax" 6 of the first paragraph of article 29.
3 service provides patients the infection. ''
Prime Minister v. Minister of Interior, Dombrovskis Health Minister ad interim Mūrniec of L.